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ABSTRACT 
 
The research presented in this thesis involves the application of chiral cationic and 
anionic surfactants for simultaneous enantioseparation of structurally similar compounds in 
capillary electrophoresis (CE) and CE coupled to mass spectrometry (CE-MS).  The first 
chapter briefly introduces the fundamentals of CE and CE-MS, emphasizing the micellar 
electrokinetic chromatography (MEKC) and MEKC-MS techniques, as well as ionic liquids 
(ILs) and affinity CE (ACE). 
 
      In chapter 2, a mixture of five racemic profen (PROF) drugs are simultaneously 
separated with the combined use of 2,3,6-tri-O-methyl-β-cyclodextrin (TM-β-CD) and IL-type 
surfactant, N-undecenoxycarbonyl-L-leucinol bromide (L-UCLB).  Enantioseparations of these 
PROFs are optimized using a standard recipe containing 35.00 mM TM-β-CD, 5.00 mM sodium 
acetate at pH 5.0, and varying the concentration as well as chain length of the IL surfactants.  
The batch-to-batch reproducibility of L-UCLB is found to be acceptable in terms of 
enantiomeric resolution, and migration time.  A competitive inhibition mechanism is proposed 
to investigate the ternary interactions among TM-β-CD, ILs, and PROFs.  The apparent binding 
constant of TM-β-CD to L-UCLB is estimated by nonlinear and linear plotting methods.  The 
binding constants of one representative PROF (e.g., fenoprofen) to TM-β-CD and to L-UCLB 
are estimated by a secondary plotting approach.  The R- and S-fenoprofen having different 
binding constant values, resulting in the enantioseparation due to the synergistic effect of TM-β-
CD and L-UCLB.  
 
       The R- and S-configurations of barbiturates display differences in potency and biological 
activity.  In Chapter 3, a multivariate MEKC-ESI-MS approach for the simultaneous analysis 
of the racemic mixture of three barbiturates is presented.  The chiral selector employed is the 
polymeric surfactant polysodium N-undecenoxycarbonyl-L-isoleucinate.  The central 
composite design is used to optimize the chiral resolution, decrease the total analysis time, and 
improve the ESI-MS signal-to-noise ratio for these barbiturates.  In preliminary experiments, 
the ranges of the factors investigated in the multivariate approaches are determined.  Then the 
multivariate optimizations are conducted to determine the best overall chiral resolution with 
shortest possible run times for barbiturates.  The limit of detection of ESI-MS is several folds 
higher compared to the UV detection.  The predicted optimum results are in good agreement 
with the experimental data. 
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1 
CHAPTER 1. INTRODUCTION 
1.1 Capillary electrophoresis  
Capillary electrophoresis (CE) is a family of separation techniques with different 
separation mechanisms.  The most simplified version is capillary zone electrophoresis (CZE), 
in which separation is based on the differences of ion linear velocity in an electric field [1].  
The ion linear velocity of a species is determined by the intrinsic ion mobility of this species and 
the voltage applied through the capillary, as shown by the following equation [1]: 
v = µ·E = µ·V/L       (Equation 1.1) 
where v represents the ion linear velocity, µ represents the mobility, E represents the electric 
field, V represents the applied voltage, and L represents the total length of the capillary [1].  
Usually, background electrolyte is used to maintain a constant electric field along the capillary 
[1].  The injected sample (analyte) incorporated in the background electrolyte will migrate with 
the linear velocity proportional to its mobility [1].  Therefore, the separation of analytes in CZE 
is caused by the different mobilities for different ionic species.   The ion mobility is related to 
the charge and size of the ions, as well as the viscosity of the solution, as can be seen in Equation 
1.2 [2]: 
µ = q/(6·π·r·η)        (Equation 1.2) 
where the µ represents the mobility, q represents the charge of the ion, r represents the 
hydrodynamic radius, η represents the viscosity of the solution [2].  The Equation 1.2 suggests 
that the smaller size and more charged molecules will have higher mobilities than larger and less 
charged ones.  The size of an ion in the solution is determined by the hydrodynamic radius of 
the ion, which refers to the radius of an equivalent sphere dependent on the structure of the ion 
[2].  Moreover, the electrophoretic mobility decreases as the viscosity of the solution is 
2 
increased.  The schematic of the movement of ions with one charge in the CE capillary is 
shown in Figure 1.1.  When positive polarity is used in CZE mode, the small positive species 
migrate fastest to the cathode since they have high charge-to-size ratio.  The large positive 
species migrate slower than the small one because of the lower charge-to-size ratio.  The 
neutral species migrate with the bulk solution at the same mobility as the electroosmotic flow 
(EOF), which will be described in section 2.  On the other hand, the negative species tend to 
migrate to the anode, and the small negative species migrate faster to the anode than the large 
negative species due to higher charge-to-size ratio.  However, the EOF of bulk solution drags 
all of the negative species moving to the cathode, resulting in the migration order of small 
positive ion, large positive ion, neutral species, large negative ion, and small negative ion, as 
shown in Figure 1.1.  
The application of Equation 2 shows limitations for the irregularly shaped ions and can 
not explain the influence of counterion atmosphere in the medium [1].  Therefore, it is more 
accurate to describe the ion mobility as follows: 
µ =       =        (Equation 1.3) 
where ε0 represents the permittivity of vacuum, εr represents the relative permittivity of the 
buffer, ε represents the permittivity of the buffer (ε = 4·π·ε0·εr), ζ represents the zeta potential [1].  
Although the zeta potential is not an easily accessible quantity to predict ion mobility, the 
physical meaning of zeta potential provides qualitative evaluation of the influence of important 
parameters on ion mobility [1]. 
The zeta potential is derived from the double layer theory, which describes the interface 
between a single ion and its counter ions and the surrounding solution [1].  The mostly accepted 
model of the double layer structure is the Gouy-Chapman-Stern (GCS) model.  As can be seen 
ε·ζ 
6·π·η 
2·ε0·εr·ζ 
3·η 
3 
in Figure 1.2, some of the counter ions are assumed to be associated with the central ions and 
form compact layer, while other freely moving counter ions form a diffuse layer around the 
central ions, resulting in an exponentially decaying potential [1].  Under the influence of an 
electric field, the associated ions and molecules will move along with the central ion, forming a 
shear plane (at the distance x=a in Figure 1.2) with the surrounding medium [1].  The zeta 
potential is the electric potential at the shear plane [1].  The relationship between zeta potential 
and the ion size, ion charge, and the buffer concentration (ionic strength) can be seen in Figure 
1.3.  According to GCS model, increasing the size of the ion pushes the shear plane outward, 
thereby reduces the zeta potential and the mobility consequently [1].  Increasing the charge of 
the ion increases the zeta potential, thereby increases the mobility of the ion [1].  When the 
ionic strength of the buffer is increased, the potential of the counter ions will decay faster, 
resulting in the decrease of zeta potential and ion mobility [1].   
 
1.2 Electroosmotic flow 
The electroosmotic flow (EOF) refers to the bulk flow of the liquid in the capillary 
caused by the effect of the electric field applied on counterions adjacent to the negatively 
charged capillary wall [3].  When a buffer at pH > 3 is flushed through a fused silica capillary, 
the inner surface of the capillary generates negative charges due to the ionization of silanol (Si-
OH) groups [2], and positive counterions in the bulk solution are concentrated to the capillary 
wall [3].  Consequently, an electric double layer structure forms on the interface between the 
capillary and the solution, as shown in Figure 1.4 [4].  According to GCS model, the double 
layer structure includes Helmholtz (compact) layer and diffused layer.  The electric potential at 
the shear plane (x=x2) is the zeta potential, as same as the one shown in Figure 1.2.[1]  The 
4 
layer of positive ions is dragged to the negative electrode (cathode) by an electric field applied 
through the capillary, resulting in the bulk flow of liquid toward the cathode, known as EOF [3].  
The relation between zeta potential and electroosmotic mobility shown below is similar to the 
one for ions, except for the proportionality factor that transfers the geometry from curve to flat 
[1]. 
µeo =       =        (Equation 1.4) 
The observed electroosmotic velocity is proportional to the applied electric field [1]: 
veo = µeo·E         (Equation 1.5) 
The direction of EOF is determined by how the inner surface of the capillary is treated.   
When the acidic silanol groups on the fused silica surface are deprotonated, the excess charge in 
the solution are cations.  The EOF will move to the direction of the cathode (Figure 1.5A) [2].  
The zero EOF (Figure 1.5B) and reverse of EOF (Figure 1.5C) can be accomplished by the static 
or dynamic wall coating [2].  The static coating is usually the chemical modification of the 
capillary wall by polymers such as polyacrylamide, polyvinylalcohol, or polyvinylpyrrolidone 
[2].  The dynamic coating involved the addition of cationic surfactants or amphiphilic polymers 
[2].  When positively charged surfactants are adsorbed to the negatively charged surface, the 
surface of the capillary will be neutralized, resulting in reduced EOF (Figure 1.5B) [2].  
Furthermore, the bilayer structure of the cationic surfactants will reverse the charges on the 
surface to positive if the concentration of surfactant is increased in the solution.  The positive 
charges on the surface of the bilayer associate with the counterions (anions) in the solution and 
form a double layer structure of anions.  This process is similar to the one generated by 
deprotonated silanol groups on the surface of bare fused silica capillary expect that the EOF is 
ε0·εr·ζ 
4·π·η  η 
ε·ζ 
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caused by the anions in the bulk solution.  Therefore, the EOF is reversed and move to the 
anode (Figure 1.5C) [2]. 
Other factors to influence the magnitude of EOF include the pH and concentration of the 
buffer used in CE [1].  The pH value of the buffer influences the deprotonation of the silanol 
groups, thereby determines the surface charge density of the fused silica capillary [1].  The EOF 
is very slow at pH lower than 3 since the surface is barely deprotonated [1].  The increase of pH 
causes the increased charge density on the surface and increased EOF.  The pH higher than 8 
still increases EOF but more modestly [1].  The concentration of buffer influences the ionic 
strength, which relates to the zeta potential and mobility [1]. When the buffer concentration or 
ionic strength increases, the zeta potential decreases and the electric double layer becomes 
thinner.  Consequently, the electroosmotic flow is decreased, which is similar to the 
electrophoretic mobility of ions [1]. 
The voltage driven flow profile of EOF in CE is shown in Figure 1.6 and compared with 
the pressure driven flow profile of mobile phase in gas chromatography (GC) or high 
performance liquid chromatography (HPLC) [2].  Research has proved that the velocity of the 
fluid in CE capillary is not a function of radial position when the inner diameter of the capillary 
is in the magnitude of µm [3].  Therefore, the flow profile of EOF is generally flat through the 
intersect surface of the capillary.  For the pressure driven flow, the velocity profile is a 
parabolic shaped laminar flow, which causes the broadening of the solute zone [3].  The flat 
profile is one of the major reasons for the high efficiency in CE separation than other techniques 
such as GC and HPLC [3]. 
The mobility or velocity experimentally measured in CE is called apparent mobility (µa), 
which is the vectorial sum of electrophoretic mobility (µep) and electroosmotic mobility [1]. The 
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apparent velocity (vapp) is the sum of electrophoretic velocity (vep) and electroosmotic velocity 
(veo).  They are defined by Equation 1.6 and Equation 1.7. 
µapp = µep + µeo       (Equation 1.6) 
vapp = µapp · E = (µep + µeo) · E = vep + veo    (Equation 1.7) 
In a fused silica capillary with positively charged inner surface, the cationic species will migrate 
to the cathode with their µapp greater than the µep and µeo.  Neutral species will migrate together 
with EOF.  The anionic species will migrate to the cathode in the same direction as EOF if their 
µep is smaller than the µeo, or in the opposite direction to the anode if their µep is greater than the 
µeo. 
The various modes and techniques of CE include capillary zone electrophoresis (CZE), 
capillary gel electrophoresis (CGE), micellar electrokinetic chromatography (MEKC), capillary 
isoelectric focusing (CIEF), capillary isotachophoresis (CITP), and capillary electro-
chromatography (CEC) [2].  MEKC is the CE technique using micelles in the CE buffers to 
separate both charged and neutral compounds.  CEC is the CE technique that combines liquid 
chromatography (LC) and CE by using packing material as stationary phase in the capillary.  
Among these modes, CZE, MEKC, and CEC are three mostly used modes in the field of CE.  
This thesis focuses on the theory related to MEKC modes and its application in analytical 
chemistry. 
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1.3 Instrumentation of CE 
The instrument of CE generally includes an electric power supply, a fused silica capillary 
with the inner diameter ranging from 20 to 200 µm, two buffer reservoirs holding the inlet and 
outlet of capillary, two electrodes connecting the power supply to the buffer reservoirs, and on-
line spectroscopic detector, as shown in Figure 1.7 [2].  The power supply provides high 
voltage through 0 to 30 kV [2].  The capillary is coated with polyimide on its outside wall to 
prevent breaking in the instrument [2].  The buffer reservoirs and electrodes connect the 
capillary to the electronic circuit.  The detector mostly used is an ultraviolet-visible (UV-Vis) 
detector measuring the UV-Vis absorption of the sample.  Before the voltage is applied, the 
capillary is first filled with background electrolyte (BGE) or buffer [2].  Next, the sample is 
injected hydrodynamically or electrokinetically into the inlet end of the capillary.  Then, the 
inlet and outlet ends are put into the buffer reservoirs with the electrodes.  The separation will 
start after the voltage is applied.  The UV-Vis absorption is monitored at an interface close to 
the outlet end of the capillary. 
 
1.4 Micellar Electrokinetic Chromatography 
The micellar electrokinetic chromatography (MEKC) was first introduced by Terabe in 
1984 for the purpose of separating neutral compounds in CE [2].  As mentioned earlier, in the 
CZE mode, the separation is simply based on the difference in electrophoretic mobilities of 
analytes [1].  The neutral compounds will migrate together with EOF and cannot be 
distinguished.  However, the use of micelles in the BGE can achieve separations of both 
charged and neutral compounds. 
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The micelles are the aggregates of surfactants, which are amphiphilic molecules with 
nonpolar, hydrophobic long chain and polar, hydrophilic head group [2].  These surfactant 
molecules spontaneously assemble to form micelles in solutions when the concentration is above 
a certain value named critical micelle concentration (CMC, Figure 1.8) [2].  In aqueous 
solution, the nonpolar long chains of the surfactant molecules form the hydrophobic core due to 
hydrophobic interaction, while the polar or ionic head groups orient towards the surface of the 
micelle and contact with the aqueous environment.  The analyte molecules can partition 
between the polar, hydrophilic aqueous solutions and nonpolar, hydrophobic micelle phase.  
Therefore, the separation of neutral compounds is achieved by the partitioning between aqueous 
phase and micelle phase.  The separation principle of MEKC is shown in Figure 1.8 [2].  The 
anionic surfactant molecules form micelles carrying negative charges.  The electrophoretic 
mobility of these micelles is toward the anode while the direction of EOF is toward the cathode.  
If the electroosmotic mobility is greater than the electrophoretic mobility of the micelles, the 
micelles will migrate to cathode after the EOF.  The analytes injected in the capillary partition 
between the micelle phase and aqueous phase due to the hydrophobicity of the analytes.  
Therefore, the neutral species have different mobilities with EOF and will elute between EOF 
and the micelles.  Different species have different hydrophobicity so that they have different 
degree of partitioning with the micelles.  The more percentage of an analyte partitions into the 
micelle, the slower this analyte migrates [2].   
MEKC shows some obvious advantages over other techniques.   The neutral and 
charged species can be separated simultaneously [1, 3].  High efficiency is achieved with 
minute consumption of samples [1, 3].  The micellar phase, known as pseudostationary phase 
(PSP), is not chemically bonded to the capillary so that it can be refreshed and changed [3].  
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The surfactants used in MEKC can be anionic, cationic, zwitterionic, nonionic, or the mixture of 
different types of surfactants that form mixed micelles [3].  In enantioselective MEKC, the 
surfactants with chiral structures are used to separate the enantiomers [3]. 
 
1.5 Ionic liquid modified MEKC 
Ionic liquids (ILs) are a class of compounds that are organic salts consisting ionic 
components with melting points at or close to room temperature (below 100°C) [5].  Due to the 
combined structures of bulk organic groups and ions, ILs show wide range of solubility in both 
polar and nonpolar solvents, and negligible vapor pressures than conventional solvents [5]. 
ILs have shown increasing applications in various research areas, including the organic 
synthesis, electrochemistry, material science, and environmental science.  Analytical chemists, 
especially those in the field of separation science, have paid more attention to ILs as stationary 
phase and mobile phase modifiers in GC and LC.  In the field of CE, ILs have been used as PSP 
in MEKC, support coatings on the capillary wall, BGE in nonaqueous CE, and additives in CE 
buffer with cyclodextrin (CD) for achiral and chiral separation.[5]  The ILs with surfactant 
properties can form micelles and be used in MEKC.  Especially, the chiral ILs have been 
reported as micelles forming surfactants for chiral separation.[6]  This thesis involves the 
application of several surfactants including the amino acid derived cationic chiral ILs used in 
MEKC, and polymeric anionic surfactants in MECK coupled to mass spectrometry (MEKC-
MS). 
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1.6 The theory for the affinity CE (ACE) and the estimation of binding constants 
1.6.1 ACE as a methodology to measure the binding constants 
The study of the association equilibrium of a dynamic chemical system requires the 
measurement of the equilibrium constant (or binding constant) [7].  Various techniques and 
experimental approaches have been used to estimate binding constants.  These techniques 
include spectroscopy, chromatography, calorimetry, and potentiometry etc [7].  In 
biochemistry, the enzyme-catalyzed reactions are investigated by measuring the substrate 
affinity to the enzyme [8].  The theory and experimental approaches have been well developed 
to deal with enzymatic reactions under various circumstances such as the inhibition of the 
enzyme-substrate reaction with different mechanisms and the enzyme reactions with multiple 
substrates [8-9].  In chemistry, the study of binding constants is usually limited to simple 
ligand-receptor reactions.  However, some reactions and systems studied in the conventional 
fields of chemistry encounter mechanisms more complicated than the ones used for reactions 
between only two reactants.  Obviously, some of the approaches used in biochemistry can be 
applied in other disciplines such as analytical chemistry.  One of the CE techniques, which 
measure the specific interactions of ligands with receptors or antigens with antibodies, is referred 
to as affinity capillary electrophoresis (ACE) [10].  When using ACE, the migration patterns of 
interacting molecules are used to identify and quantify specific binding and to estimate binding 
constants in two steps: (1) the solutes are first separated by CZE, (2) the CE run buffer is doped 
with a complexing agent, which is specific for the solute.  The change in tR of the solute is 
recorded before and after the addition of complexing agent [10].  Strictly speaking, MEKC can 
also be considered as an ACE method since the partitioning and the electrostatic interactions 
between the solute and the micelles are the affinity interactions between these two species [10].  
11 
However, most of the reactions studied by ACE are noncovalent molecular interactions confined 
to ligand-receptor or ligand-substrate mode [10].   
A molecular association between an analyte and a ligand can be described by the general 
rectangular hyperbolic form of a binding isotherm equation shown below [11]: 
y =
ax
b + cx         (Equation 1.8) 
where y is the experimentally measured response of the ligand-substrate system [11].  The free 
variable x is the concentration of free ligand.  The a, b, and c are constants determined by the 
properties of the substrate, ligand, and complex, and they also include the information of the 
binding constants and stoichiometry [11].  This binding isotherm equation is used in many 
fields of chemistry and biochemistry to estimate the binding constant.  To generate the signal 
response y, various spectroscopic methods have been used, such as UV-Vis absorption, IR 
absorption, and NMR [10].  Other techniques such as electrochemical methods, 
chromatography, and calorimetry have also been applied to provide different signals between the 
bound and free substrate [10].  All these methods utilize different physical properties inherent 
to the complex and free form of analytes, such as extinction coefficients in spectroscopy, 
chemical shifts in NMR, and electrophoretic mobility in electrophoresis [7]. 
 
1.6.2 The derivation of the isotherm equation in CE  
In a 1:1 ligand-substrate reaction, the equilibrium constant of the affinity of the ligand 
molecule to the substrate is governed by the law of mass action [10]. 
S + L SL 
Keq =
[SL]
[S] [L]        (Equation 1.9) 
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where [S] represents the substrate concentration, [L] represents the ligand concentration, and 
[SL] represents the concentration of the complex formed by substrate and ligand (assuming the 
activity coefficients is neglected and set to unity) [10].  In equation 1.9, Keq is the equilibrium 
constant of the reaction (also known as association constant).  Because the association constant 
provides the measurement of the ligand affinity to a substrate, it can also provide the energetics 
of ligand/substrate binding by the following thermodynamic relationship: 
ΔG = - RT ln Keq        (Equation 1.10) 
In equation 10, ∆G is the Gibbs free energy change of the binding reaction, R is the gas constant, 
and T is the absolute temperature [10]. 
In ACE approach, a low concentration of substrate is injected into a capillary filled with 
the ligand at a concentration [L] [10].  Once the dynamic equilibrium is established, the 
effective net mobility of the substrate (µ) is the combination of the mobility of free and bound 
substrate weighted by their molar fractions [10]: 
μ = xS μ S xSL μSL+       (Equation 1.11) 
where μS is the effective mobility of the free substrate, μSL is the effective mobility of the bound 
substrate, xS and xSL are the molar fraction of the free and bound substrate, respectively [10].  
The molar fractions are expressed as 
xS = [S] [SL]+
and xSL= [S] [SL]+
[SL][S]
     (Equation 1.12) 
Similar to chromatography, the ratio of bound to free substrate molecules is defined as capacity 
factor k’ [10]: 
k' =
n
nS
SL
=
[SL]
[S]
= Keq [L]
      (Equation 1.13) 
Combining Equation 1.13 and Equation 1.12 gives 
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xS = 1 k'+
1
xSL= 1 k'+
k'
and=
[S]
[SL]+
1
1
=[S]
[SL]
1 +
[S]
[SL]
  (Equation 1.14) 
In the absence of the interactions to capillary wall, and without other species of substrate, 
Equation 1.11 is simplified to: 
μ = xS μ S xS μ SL+ 1 - 1 k'+
1
= μ S + 1 k'+
k' μ SL
 (Equation 1.15) 
Replacing k’ with Equation 1.13 gives 
μ =
1 + Keq [L]
μS + Keq [L] μSL
1 +
1 μS +
1 +
μ SLKeq [L] Keq [L]
Keq [L]
=
 (Equation 1.16) 
To fit with the form of Equation 1.8, Equation 1.16 is transferred to an isotherm equation: 
μ − μS =
1 + Keq [L]
μS Keq [L]μSL-Keq [L] μSL μ- =
   (Equation 1.17) 
In Equation 1.17, the dependent variable, which is the y in equation 1.8, is the value of μ-μS, 
which is the change of the effective mobility of the analyte under the presence and absence of 
ligand in the buffer, the a term (in Equation 1.8) is (μSL-μS)•Keq, the b term is 1, and the c term is 
Keq.  The y is decreasing with the increasing [L] (the x in Equation 1.8), which shifts the 
binding reaction to form more bound substrate SL, and increase the weight of µSL in the net 
mobility µ, as shown in Equation 1.15 [10].  The values of [L] are set for a serious of CE 
buffers, the values of µ are obtained from the electropherograms, and then the Keq can be 
obtained from the isotherm plot [10]. 
The isotherm equation used in enzyme kinetics is called Henri-Michaelis-Menten 
equation [8].  However, the enzymatic reaction is the rapid equilibrium between the free 
enzyme and substrate to form the enzyme-substrate complex (ES), followed by another step to 
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release the product [8].  The application of Henri-Michaelis-Menten equation is limited to the 
condition when the concentration of ES reaches a steady state [8].  In the field of enzyme 
kinetics, the steady state is defined as a time period of the enzymatic reaction during which the 
rate of ES formation is exactly matched by its rate of decay to free enzyme and products [8].  
Therefore, the experimental measurement of signal response should be conducted when ES is 
present at the steady state [8]. 
The data treatment of isotherm plot is difficult without the help of computers.  However, 
evaluation of experimental data is possible by converting Equation 1.17 to a linear form.  The 
three linearized equations used for plotting methods are shown below [10]: 
X-reciprocal equation (Eadie-Scatchard equation in biochemistry): 
μ μS-
[L]
= Keq- μ μS- + μS-μSLKeq
     (Equation 1.18) 
Y-reciprocal equation: 
= +
1
μS-μSL
1[L]
μ μS- [L] Keq μS-μSL      (Equation 1.19) 
Double reciprocal equation (Lineweaver-Burk equation in biochemistry): 
= +
1 1
μ μS-
1
Keq μS-μSL
1
[L] μS-μSL      (Equation 1.20) 
To draw the plots for Equation 1.18, 1.19, and 1.20, the y axis is the term at the left side of each 
equation, the x axis is (µ-µS), [L], and 1/[L], respectively.  Linear regression equations can be 
obtained from these plots.  The values of Keq can be obtained from the intercepts and slopes of 
these linear plots without difficulty.  For X-reciprocal plotting method, the slope of the linear 
regression line is –Keq, and the value of Keq is calculated from the negative value of the slope.  
For Y-reciprocal plotting method, the slope is 1/(µSL-µS), the intercept is 1/(Keq·(µSL-µS)), the 
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value of Keq is calculated from slope/intercept.  For double reciprocal plotting method, the 
slope is 1/(Keq·(µSL-µS)), the intercept is 1/(µSL-µS), the value of Keq is calculated from 
intercept/slope. 
These transformations change the statistical weights of the data points and thereby show 
different uncertainties for the value of Keq [10].  For example, in the double reciprocal plot, 
there is more emphasis on the data points corresponding to the lowest values of the ligand 
concentration.  As a result, the estimated mobility of the complex, µSL, shows more 
uncertainties at the point of intersection [10].  There are various reasons that can cause 
deviations from linearity.  For instance, slow equilibration, adsorption at the capillary wall, and 
the presence of higher order equilibriums often cause lower correlation coefficients, which in 
turn cause incorrect value of equilibration constants.   
 
1.7 CE-mass spectrometry (CE-MS) and MEKC-MS  
Mass spectrometer is the device that ionizes molecules (charged molecules or ionized 
fragments) in the gas phase using an ionization source, then separates the ions according to their 
mass to charge ratio by the mass analyzer, and finally detects the gas phase ions by the electron 
multiplier [3].  Mass spectrometry is considered as an important technique to extract the ion 
from a mixture and provide the structural information of the analyte molecules [3].  The use of 
MS as a detector for CE can easily identify the analyte and significantly improve the limit of 
detection [3]. 
The most widely used ionization technique of MS coupled to CE is the electrospray 
ionization (ESI), which uses an electrospray interface to connect the capillary outlet from CE 
instrument to the electrically induced nebulization process in the MS instrument [3].  A flow of 
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dry nitrogen helps the evaporation of the highly charged droplets until these droplets break up to 
gaseous ions flying into the highly vacuumed MS detector [3].  The MS can be coupled to CZE, 
MEKC or CEC in a commercial CE-MS instrument to combine the advantages of both CE and 
MS.  Especially, the high efficiency of separation and high sensitivity of detection are achieved 
for the simultaneous separation. This thesis also focuses on the MEKC-MS and its application 
for the simultaneous enantioseparation of barbiturates [7, 12-15]. 
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Figure 1.1 The electrophoretic mobilities of negatively charged, positively charged, and neutral 
species in CE. (Taken from 3D-CE/MSD ChemStation software, Agilent Technologies, Inc.) 
 
Figure 1.2 The Gouy-Chapman-Stern model of the electric double layer structure surrounding a 
cation [1].  r = geometric ion radius, a = shear plane, δ-1 = Debye length (used in physical 
chemistry) [1]. 
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Figure 1.3 The effects of size, charge, and buffer concentration on the zeta potential [1].  
 
Figure 1.4 The Gouy-Chapman-Stern model of the electric double layer structure formed 
between capillary wall and the solution.  x2 = shear plane.  The curve shows the potential 
profile through the solution side of the double layer [4]. 
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Figure 1.5 The schematic of EOF in the capillary.  (A) The generation of EOF, (B) the 
reduction of EOF, (C) the reversal of EOF [2]. 
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Figure 1.6 The flow profiles and corresponding solute zones of voltage driven system (CE) and 
pressure driven system (GC, HPLC) [2]. 
 
 
 
Figure 1.7 The schematic of CE instrument [2]. 
 
 
CE GC and HPLC 
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Figure 1.8 The illustration of the separation principle of MEKC (using negatively charged 
surfactants in aqueous solutions) [2]. 
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CHAPTER 2. COMBINED USE OF IONIC LIQUIDS AND CYCLODEXTRIN FOR 
SIMULTANEOUS ENANTIOSEPARATION OF ANIONIC PROFENS 
2.1 Introduction 
Separations of chiral compounds on analytical-scale are subject to immense interest. This 
is mainly because currently there are strict regulatory issues for the preparation of 
enantiomerically pure compounds.  Therefore, dedicated analytical assay for enantiomeric 
purity are essential for drug screening in the pharmaceutical industry.  In addition, chiral 
discrimination has also been shown to be increasingly important in agricultural, environmental 
and biological sciences [1].  Capillary electrophoresis (CE) has proved to be an effective tool 
for chiral discrimination, studying chiral interactions and measurement of binding constants of 
enantiomers.  This is due to high efficiency, short analysis time and requirement of only a small 
quantity of exotic chiral selector.  Among the various chiral reagents, native cyclodextrins 
(CDs) and their derivatives [2] macrocyclic antibiotics [3] as well as polymeric surfactants [4] 
have proven to be very successful for CE.  However, the utility of the aforementioned reagents 
as a single chiral selector to resolve enantiomers is not always satisfactory.  Hence, the utility 
of more than one chiral reagent in CE to improve the enantioseparation has drawn increase 
attention in recent years [5-7]. 
Ionic liquids (ILs) are organic salts consisting ionic components with low melting points 
(i.e., at or close to room temperature) [8-9].  Very recently, our group reported the first use of 
two new cationic ILs type surfactants as a single chiral selector in micellar electrokinetic 
chromatography (MEKC) [10].  Subsequently the cationic IL, N-undecenoxyl-carbonyl-L-
leucinol bromide (L-UCLB) and N-undecenoxyl-carbonyl-L-pyrrolidinol bromide (L-UCPB) 
and their polymers were synthesized, characterized and compared for the enantioseparation of 
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two negatively charged enantiomers (α-bromo-phenyl acetic acid, and phenoxy propionic acid).  
The primary interaction of afore-mentioned ILs is thought to involve electrostatic attractive 
interactions.  Proposed secondary interactions include steric, hydrophobic and hydrogen-
bonding interactions.  Very recently, the combined use of various CD derivatives and two chiral 
ILs (ethyl- and phenyl-choline of bis (trifluoromethylsulfonyl) imide) was evaluated for 
enantiomeric separations by CE.  Although no clear trend was observed, enhancement in chiral 
selectivity and resolution of two profens (e.g., carprofen and suprofen) were achieved, which 
suggests synergistic effect [11].  A similar report on the use of chiral IL, S-[3-(chloro-2-
hydroxypropyl)trimethylammonium][bis(trifluoromethyl)sulfonyl]amide has been reported in 
combination with 1-S-octyl-β-D-thiogluco-pyranoside (OTG) and/or sodium cholate for the 
enantioseparation of ibuprofen and flurbiprofen, respectively [12]. 
This work is focused on the combined use of cationic IL-type surfactants (L-UCLB) and 
heptakis 2,3,6-tri-O-methyl-β-CD (TM-β-CD) as a dual chiral selector for MEKC.  Because L-
UCLB did not provide any enantioselectivity with regard to model class of analytes (PROFs) 
under the reversed electroosmotic flow (EOF) MEKC, the influence of L-UCLB was studied in 
combination to TM-β-CD under the normal EOF MEKC.  As demonstrated in this paper, the 
presence of L-UCLB would widen the scope of application of TM-β-CD.  For example, the 
widening of the chiral window was obtained upon addition of L-UCLB.  This implies that 
simultaneous enantioseparation of the five structurally similar aryl-propionic acids (PROFs) 
would be achieved in a high throughput fashion.  The enantiomeric resolution, selectivity and 
the total analysis time were compared using concentration and chain length of ILs.  In addition, 
batch-to-batch reproducibility of IL surfactants for the simultaneous enantioseparation was also 
compared.  Finally, an approach originated from enzyme kinetics was used to study the binding 
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constants of L-UCLB to TM-β-CD, PROFs to TM-β-CD, and of PROFs to L-UCLB.  This 
approach is applicable based on the assumption that two or more additives have significant 
interactions with each other.  We hypothesize that the IL, L-UCLB act as an “inhibitor”, 
reducing the interaction between TM-β-CD and the PROFs.  To test the aforementioned 
hypothesis, we proposed a general model for the ternary interactions among profens, TM-β-CD 
and L-UCLB.  To the best of our knowledge, this is the first study in which the simultaneous 
enantioseparation of PROF drug is achieved using a mixture of IL and TM-β-CD as a dual chiral 
selector.   
 
2.2 Materials and methods 
2.2.1 Reagents and chemicals 
The five PROF compounds (ibuprofen, fenoprofen, indoprofen, suprofen, and 
ketoprofen), dimethyl sulfoxide (DMSO, anhydrous, 99.9+%), and TM-β-CD were purchased 
from Sigma-Aldrich (St. Louis, MO, USA).  Sodium acetate was purchased from Fisher 
Scientific (Chemical Manufacturing Division, Fair Lawn, NJ, USA).  Acetic acid, 
dichloromethane, ethyl acetate, and acetone were purchased from Caledon Laboratories 
(Georgetown, ON, Canada).  Deionized water was prepared with a Barnstead “NANOpure” 
ultrapure water system (Dubuque, Iowa, USA).  
The reagents ω-undecylenyl alcohol, 2-bromoethylamine hydrobromide, pyridine 
anhydrous, S-(+)-leucinol, formic acid (≥95), and formaldehyde (37 wt. % solution in water) 
used for the synthesis of ILs were purchased from Sigma-Aldrich (St. Louis, MO, USA).  7-
Octen-1-ol and triphosgene were obtained from TCI (Tokyo Kasei Kogyo Co. LTD, Tokyo, 
Japan).  Hydrochloric acid and sodium sulfate anhydrous were purchased from EMD Chemicals 
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(Gibbstown, NJ, USA).  Sodium bicarbonate was purchased from Mallinckrodt Baker 
(Phillipsburg, NJ, USA).  Sodium hydroxide (50% w/w) was purchased from Fisher Scientific 
(Pittsburgh, PA, USA).  Two ILs, L-UCLB and N-octenoxycarbonyl-L-leucinol (L-OCLB, 
Figure 2.1) were synthesized following a previously optimized procedure [10].  
 
2.2.2 CE instrumentation 
All CE experiments were performed on an Agilent CE system (Agilent Technologies, 
Santa Clara, CA, USA) equipped with an on-line diode array detector (DAD) for the absorbance 
measurements at 214 nm.  The temperature control of the sample carousel at 16 °C was 
maintained by Fisher ISOTEMP 3016S refrigerating circulator (Fisher Scientific, Pittsburgh, PA, 
USA).  The 3D-CE Chemstation software was used for the instrumental control, data 
acquisition, and data analysis.  The fused silica capillaries (Polymicro Technologies, Phoenix, 
AZ, USA) with dimensions of 64.5 cm total length, 56.0 cm effective length, 50 μm i.d., and 365 
μm o.d. were used throughout the study.  The exact values of the total length and effective 
length of the capillaries were measured and used for the calculation of binding constants.   
 
2.2.3 CE conditions and methods 
2.2.3.1 Simultaneous enantioseparation of profen drugs using L-UCLB and L-OCLB 
The concentration of each PROF stock solution prepared in pure MeOH was 2.0 mg/mL.  
A fixed aliquot of ibuprofen, fenoprofen, indoprofen, suprofen, and ketoprofen racemates were 
respectively dissolved in a binary solvent mixed with MeOH and H2O in the ratio of 70:30 (v:v).  
The 5 mM NaOAc solution was prepared by dissolving NaOAc·3H2O in triply DI water. The pH 
of this solution was adjusted to 5.0 using 15.1 μL of 17.4 M HOAc solution.  A bare fused 
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silica capillary was first preconditioned for 60 minutes with 1 M NaOH at 50 °C, and then 
flushed for 30 min with triply DI water at 16 °C.  Before each injection, the capillary was 
flushed with the separation buffer for 5 min.  After each run, the capillary was postconditioned 
with DI water for 5 min, 0.1 M aqueous NaOH solution for 10 min, and DI water for 5 min.  
The sample was hydrodynamically injected at 3 mbar, 8 seconds.  The separations were carried 
out under an applied voltage of +30 kV and a temperature of 16 °C.  The absorbance of PROF 
drugs in the CE buffer was monitored at 214 nm. 
 
2.2.3.2 Estimation of the binding constant between TM-β-CD and L-UCLB (K1) 
The stock solution of L-UCLB was prepared by dissolving in 5 mM NaOAc aqueous 
buffer (pH 5.0) at the concentration of 4.0 mM. The DMSO was dissolved in 5 mM NaOAc 
buffer (pH 5.0) at the concentration of 0.1 mg/mL.  Consequently, 100 μL of L-UCLB and 
DMSO solutions were added to a vial and vortexed to make a mixture solution to be injected into 
the capillary with an injection size of 50 mbar, 20 sec.  The CE buffers used in this study were 
5 mM NaOAc aqueous buffer (pH 5.0) without TM-β-CD, and the same buffer with TM-β-CD at 
concentrations ranging from 2.5 mM to 10.0 mM.  The capillary rinsing procedure before the 
first run, the precondition before each run, and the postcondition after each run were generally 
the same as described in section 2.3.1 except that the postcondition of 0.1 mM NaOH was 5 min 
instead of 10 min.  The separations were carried out with an applied voltage of +20 kV and a 
temperature of 16 °C.  The direct UV detection of L-UCLB was achieved at 200 nm. 
The addition of TM-β-CD in the CE buffer will change the viscosity of the buffer, and 
thereby affect the mobility of the L-UCLB in the buffer with different concentration of TM-β-
CD [13-14].  To study this effect, the relative viscosities of the TM-β-CD buffer were measured 
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by hydrodynamic injection of the sample containing 2.0 mM L-UCLB and 0.05 mg/mL DMSO 
in 5 mM NaOAc buffer (pH 5.0) with the injection size of 50 mbar, 20 sec.  The sample was 
pushed through the detector with a constant pressure of 50 mbar [13-14].  The viscosity 
correction factor was estimated using the following equation: 
=ν tt0= η0
η
, 
where η0 is the viscosity of the CE buffer without TM-β-CD, and η is the viscosity of the CE 
buffer with a certain concentration of TM-β-CD [13-14].  The time t0 and t represent the time 
required for the sample plug to move through the injection end of the capillary to the detector in 
a CE buffer without and with a certain concentration of TM-β-CD, respectively.  The sample 
plugs used to estimate the relative viscosity were monitored at 200 nm. 
Affinity capillary electrophoresis (ACE) is widely used to measure the binding constant 
[15].  This method is based on the changes of effective mobilities of the free and bound forms 
of analytes due to the association-dissociation kinetics between the analyte and ligand [15].  
The shift of the position of the L-UCLB peak relative to the position of the TM-β-CD peak was 
measured with the increasing concentration of TM-β-CD.  The neutral marker, DMSO, was 
used to indicate the position of TM-β-CD peak and calculate the effective mobilities of free and 
bound L-UCLB.  The binding constant between L-UCLB and TM-β-CD (K1) was estimated by 
the linear plotting methods using Microsoft Excel software (version 2007), as listed in Table 2.1.  
The plots used were X-reciprocal, Y-reciprocal, and double-reciprocal methods [15].  In the 
equations shown in Table 2.1, µf is the effective mobility of the free form of L-UCLB in the 
absence of TM-β-CD, µi is the effective mobility of the L-UCLB in equilibrium with TM-β-CD 
in serial CE buffers containing increasing concentrations of TM-β-CD.  The µc is the effective 
mobility of the TM-β-CD/L-UCLB complex form at saturating conditions, which is difficult to 
(Equation 2.1) 
28 
measure experimentally but can be easily obtained from any standard nonlinear regression 
software [14, 16].  The ν is the viscosity correction factor, as we described before.  The values 
of binding constant K1 were calculated from the slopes and intercepts of the linear plots, as 
shown in Table 2.1 [14, 16].  The nonlinear isotherm plot was obtained by a nonlinear 
regression fitting equation shown in Table 2.1 [14, 16].  The Origin (version 7.5) software was 
used for the data treatment of nonlinear plotting method [14]. 
 
2.2.3.3 Estimation of the binding constants of fenoprofen to TM-β-CD and fenoprofen to  
      L-UCLB (K2 and Ki) 
The stock solutions of fenoprofen (0.20 mg/mL) and DMSO (0.50 mg/mL) were prepared 
in 5 mM aqueous buffer of NaOAc at pH 5.0.  The mixture solution to be injected into the 
capillary was made by adding 100 μL of each stock solution of fenoprofen and DMSO in a 
sample vial.  The mixture was then injected with the injection size of 5 mbar, 10 sec.  The 
concentrations of TM-β-CD ranged from 1.0 to 50 mM.  The viscosity correction factors for 
these buffers were obtained by the same method described in section 2.3.2.  The binding 
experiment for measurement of K2 was performed under a voltage of +10 kV, temperature of 16 
°C with UV detection at 200 nm.  The migration time of R and S enantiomers of fenoprofen was 
used to estimate the binding constants. 
The K2 value between TM-β-CD and fenoprofen enantiomers were obtained from the 
same double-reciprocal plotting method described in section 2.3.2.  The values of K2 were 
different in the absence and presence of L-UCLB.  The inhibition constant Ki was estimated 
from a secondary plot obtained by the method originated from enzyme kinetics [17, 18].  The 
details of inhibition study are explained in section 3.2. 
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2.3 Results and discussion 
2.3.1 Studies on simultaneous enantioseparation of profens 
2.3.1.1 Evaluation of synergistic effect between L-UCLB and TM-β-CD  
 With a goal to extend the enantioselective capability of L-ULCB, a series of structurally 
similar anionic drugs (e.g., PROFs, shown in Figure 2.1) was investigated.  No 
enantioselectivity was observed for any PROF drug when using L-UCLB as a single chiral 
selector.  It is well-documented that among the several native and derivatized CDs, the TM-β-
CD is the best chiral selector for the separation of PROFs [19].  Next, we investigated the 
association between L-UCLB and TM-β-CD to search for possible synergistic effects.  As 
shown in Figure 2.2A, TM-β-CD exhibits reasonable enantioselectivity for individual anionic 
PROFs, but it was less successful in completely resolving the PROF enantiomers in complex 
mixtures of structurally similar PROFs.  For example, only slight resolution was observed for 
ibuprofen enantiomers (1,1’).  In addition, the later eluting enantiomers of indoprofen (3’) co-
eluted with the first eluting enantiomer of suprofen (4).  Hence, TM-β-CD only partially 
separated the enantiomeric mixture of PROFs with a narrow chiral window.  However, upon 
addition of 1.5 mM L-UCLB to the CE buffer containing TM-β-CD, all enantiomers of PROFs 
were baseline resolved (except for ibuprofen, which provided Rs value of 1.32) with a significant 
widening of the chiral window (Figure 2.2B).  Furthermore, the peak efficiency improved by 3-
10 times (data not shown).  We hypothesize that these improvements in simultaneous 
enantioseparation of PROFs are due in large part to the interaction between TM-β-CD and L-
UCLB, which in turn reduces the interaction of the L-UCLB with the capillary wall.  
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2.3.1.2 Evaluation of the profen/TM-β-CD/IL interaction system 
 The five PROF enantiomers (Figure 2.1) studied in this work have pKa values less than 
5.0, and the background electrolyte, sodium acetate used in this work, has a pH value of 5.0.  
Therefore, all of the PROFs were partially anionic in the CE buffer.  During the MEKC 
separation, the capillary is filled with the CE buffer contained three major species: the neutral 
chiral selector TM-β-CD, the positively charged chiral selector L-UCLB, and negatively charged 
analytes PROFs.  As can be seen in Figure 2.3, the interactions among these species could be 
divided into three parts: (a) the interactions (K1) between the TM-β-CD and the IL monomers or 
micelles, (b) the interactions (Ki) between the PORFs and IL monomer or micelles, and (c) the 
interactions (K2) between PROFs and TM-β-CD.  The monomer of IL might form inclusion 
complex with TM-β-CD.  It should be noted that he IL monomers or micelles are cationic while 
the PROFs are anionic.  Hence, the interactions between these two species might include 
electrostatic attraction (ion-pair), hydrogen bonding, and hydrophobic interactions.  In addition, 
the PROFs might also form inclusion complex with TM-β-CD.  When a positive polarity was 
used in CE separation, the L-UCLB monomer or micelles migrated before EOF, TM-β-CD 
migrated with EOF, and PROFs migrated after EOF.  It cannot be ascertained from the 
schematic (shown in Figure 2.3) whether the anionic PROFs partition exclusively to the TM-β-
CD cavity or whether the PROF-(L-UCLB) complex is included in the TM-β-CD cavity.  
Nevertheless, the interactions among these species caused the differential binding forces between 
the racemic pairs of the PROFs and the two chiral selectors TM-β-CD and L-UCLB; thereby the 
enantioseparation could be achieved.   
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2.3.1.3 Influence of ionic liquid concentration on resolution and migration time 
Figure 2.4 shows the electropherograms illustrating the effect of low mM concentrations 
of L-UCLB as an additive to the TM-β-CD buffer.  The increasing concentrations of L-UCLB 
from 1.0 to 3.0 mM had a significant influence on the resolution and migration time of anionic 
PROFs.  As can be seen in Figure 2.4A-C, the chiral and achiral resolutions of all PROFs 
increased, comparing to the ones in Figure 2.4A.  In addition, the electroosmotic mobility 
decreased dramatically over the same concentration range from 1.998×10-4 cm2·V-1·s-1 to 
8.964×10-5 cm2·V-1·s-1 due to adsorption of L-UCLB to the capillary wall.  The inset plot in 
Figure 2.4 shows that the increasing concentration of L-UCLB caused the highest change in 
resolutions of fenoprofen racemate (from 2.6 to 5.0) and the smallest change in the resolution of 
ibuprofen racemate (from 1.1 to 1.7).  Furthermore, the achiral resolution between critical pair 
of indoprofen and suprofen (3’/4) also increased from 1.7 (1.0 mM L-UCLB) to 1.9 (3.0 mM L-
UCLB).  However, the continuous increase in migration times made the buffer with 
concentration higher than 3.0 mM L-UCLB not applicable.  The optimum concentration of L-
UCLB for simultaneous enantioseparation seems to be 2.0 mM, which provides a good 
compromise between analysis time and resolution values.  
 
2.3.1.4 Batch-to-batch reproducibility 
We also investigated the batch to batch reproducibility of the L-UCLB synthesis.  
Figure 2.5 is a representative series of electropherograms for the simultaneous enantioseparation 
of profens using three batches of L-UCLB.  All three electropherograms were generated under 
same buffer conditions using the same capillary.  The %RSD of electroosmotic mobility was 
0.84%.  The %RSD for the average efficiency of each batch is 7.53%, whereas the %RSD for 
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the migration time of the profens range from 1.06% to 2.56%.  The %RSD of the resolution 
between two consecutive profen peaks in Figure 2.5 (i.e., from peak 1 to 5’) were 8.47%, 8.68%, 
6.76%, 3.66%, 3.27%, 5.00%, 3.09%, 3.20%, 4.79%, and 7.76%.  Therefore, it can be 
concluded that the procedure for synthesis of L-UCLB is sufficiently reproducible. 
 
2.3.1.5 Influence of chain length 
Previously, the polymeric anionic surfactants with leucinate head group and C8-C11 chain 
length were evaluated for the simultaneous enantioseparation of eight β-blockers [20].  The 
eight carbon chain chiral surfactant provided the overall best enantioselectivity.  However, the 
anionic chiral polymeric surfactants are not very suitable for anionic chiral analytes.  To study 
the effect of the chain length, we synthesized another cationic IL such as L-OCLB with eight 
carbon chain.  A generalized structure of optically pure cationic surfactant can be seen in Figure 
2.1.  The only difference between these two chiral surfactant-type IL L-UCLB and L-OCLB is 
the length of the hydrocarbon chain attached to the leucinol head group via carbamate linkage.  
Figure 2.6 compares the simultaneous enantioseparation of five profen drugs using the same 
concentration of L-UCLB (Figure 2.6A) and L-OCLB (Figure 2.6B).  As expected, the 
migration times of all profens and EOF in Figure 2.6A are all longer with the use of eleven 
carbon chain IL micelles than the use of eight carbon chain IL micelle (Figure 2.6B).  For 
example, the migration time of the latest peak (S-ketoprofen) eluted at 52.3 min when using L-
UCLB, while it eluted at 44.8 min when using L-OCLB.  However, unexpectedly, the chiral 
resolutions and selectivities of the racemic profen pairs did not change very much.  This study 
suggests that L-UCLB and L-OCLB performed similar binding interactions with TM-β-CD.   
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2.3.2 Theory of the binding constants and mechanism of separation 
As discussed above, the ILs are the micelle of a cationic surfactant, while the PROFs are 
partially anionic in the MEKC buffer.  If the interactions between these two species are strong, 
the PROFs should migrate with ILs and before EOF.  However, the PROFs eluted after the 
EOF, and the migration time of PROF increased with the increasing concentration of ILs.  This 
phenomenon indicates that both TM-β-CD and the ILs played an important role for the 
enantioseparation.  In this section, we propose an inhibition mechanism for the interactions of 
PROF with L-UCLB and TM-β-CD.  The concept of inhibition originated from enzyme 
kinetics.  It is well-known that the enzyme and substrate have specific interaction between each 
other, and an inhibitor may also bind to the same enzyme [17].  For the competitive inhibition, 
the inhibitors can exclusively interact with the free enzyme.  In other words, the enzyme binds 
either the substrate or the inhibitor, but not both simultaneously.  For noncompetitive 
inhibition, the inhibitor binds with free enzyme and with enzyme-substrate complex 
simultaneously.  In case of uncompetitive inhibition, the inhibitor binds exclusively with 
enzyme-substrate complex [17].    
In our system, we hypothesize that the L-UCLB and TM-β-CD are competing with each 
other for the binding sites on the PROF.  The addition of L-UCLB to the TM-β-CD could 
decrease the interaction between the PROF and TM-β-CD, thereby inhibiting the formation of 
PROF-(TM-β-CD) complexes.  Moreover, the interaction between the two chiral selectors (i.e., 
L-UCLB and TM-β-CD) also decreases the binding of the PROF to each of them.  During the 
separation, the PROFs had weaker interactions with both TM-β-CD and ILs due to this inhibition 
mechanism, which probably resulted in the enantioseparation.  The reactions for the 
competitive inhibition mechanism are shown as follows: 
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Scheme 1. competitive inhibition: 
 
where PROF-CD represents the complex formed between profens and TM-β-CD, PROF-IL 
represents the complex formed between profens and ILs, CD-IL represents the complex formed 
between TM-β-CD and ILs.  Note that the inhibitor L-UCLB has interactions with both PROFs 
and the TM-β-CD, so it inhibited the chiral interaction between TM-β-CD and PROFs.  In 
addition to competitive inhibition, noncompetitive and uncompetitive inhibitions are also 
possible. 
Scheme 2 represents a noncompetitive inhibition in which the L-UCLB binds with the 
free PROF and with PROF-CD complex. 
Scheme 2. noncompetitive inhibition: 
 
where PROF-IL and PROF-CD represent the same complexes as mentioned above.  However, 
the PROF-CD-IL represents the ternary complex eventually formed by the three species profen, 
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TM-β-CD, and L-UCLB.  The binding of L-UCLB can also occur exclusively with PROF-CD 
complex, which can mimic uncompetitive inhibition model as shown below in Scheme 3.   
Scheme 3. uncompetitive inhibition:  
 
In the above Scheme 3, the profen firstly binds to TM-β-CD, and then to L-UCLB.  The final 
product is the PROF-CD-IL, which is essentially the same ternary product as the one shown in 
Scheme 2.  
The double-reciprocal plot (or Lineweaver-Burk plot in biochemistry) can be used to 
determine the mode of inhibition [17, 18].  The double-reciprocal plots for the binding of TM-
β-CD and the PROF sample were obtained under several fixed concentrations of the inhibitor L-
UCLB, respectively (see section 2.3.3).  Overlaying these straight lines will show a pattern that 
can determine the type of inhibition.  For example, the linear plots obtained for competitive 
inhibition will show same y intercept values but increasing slope values with the increase of 
inhibitor concentration.  On the other hand, the overlaid plots for uncompetitive inhibition 
should appear as a series of parallel lines that intersect the y axis at different y values.  For the 
noncompetitive inhibition, both the slope and the y intercept of the double-reciprocal plot will 
increase with increasing concentration of the inhibitor. 
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2.3.2.1 Determination of TM-β-CD/L-UCLB binding constant (K1) 
To investigate the mechanism of inhibition, the binding constant between TM-β-CD and 
L-UCLB was first measured by the conventional linear plotting methods used in most of the 
published work related to ACE [21-25].  As mentioned earlier, Figure 2.4 suggests that the 
migration time of the EOF shifted with increasing concentration of L-UCLB, which is due to the 
increase in viscosity of the MEKC buffer.  Therefore, we had to allow for viscosity correction 
when calculating the L-UCLB effective mobilities (see section 2.3.2).  Table 2.1 shows the four 
equations used to estimate the binding constant K1 between TM-β-CD and L-UCLB after 
multiplying the mobilities with the viscosity correction factor (ν).  The effective mobilities of 
L-UCLB (µf and µi) were calculated at different concentrations of TM-β-CD.   
The four equations shown in Table 2.1 are equivalent in their algebraic forms.  
However, the experimental precision on the dependent and independent variables will affect the 
correlation differently [15].  This difference will be dependent on whether the variables are 
placed in the numerator or denominator of the equation.  For instance, the effect of the 
precision on variable [TM-β-CD] will alter when the data are transferred to 1/[TM-β-CD] for 
plotting in the X-reciprocal and double-reciprocal methods.  Moreover, it is worth mentioning 
that X-reciprocal, Y-reciprocal, and double-reciprocal methods can not measure the actual 
mobilities of the complexed L-UCLB cation (µc) whereas the nonlinearized regression of 
isotherm equation can provide the value of µc using any standard software [14-16].  In general, 
a good estimation of µc can be obtained by measuring the limited effective mobility of the L-
UCLB cation at very high TM-β-CD concentration [14-16].   
The data treatment of the free and complex mobility as well as the viscosity correction is 
tabulated in Table 2.2.  Figure 2.7 shows the electropherograms obtained with a bare silica 
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capillary filled with various concentration of TM-β-CD.  Upon increasing the concentration of 
TM-β-CD, an increase in migration time of L-UCLB cation was observed.  This relationship 
indicates a decrease in charge-to-mass ratio of L-UCLB once complexed with TM-β-CD.  The 
time difference between the peaks of L-UCLB and TM-β-CD (the same peak as neutral marker) 
decreased gradually with the increasing concentration of TM-β-CD, and the binding constant 
was estimated from this time difference.   
Figure 2.8A-C shows the linearized representations (X-reciprocal, Y-reciprocal, double-
reciprocal plots, see Table 2.1 for equations of the 1:1 binding isotherm for (L-UCLB)-(TM-β-
CD) complex).  Note that the negative deviation in linearity on the y-axis at the x-axis maxima 
(low TM-β-CD concentration) of the double-reciprocal plot (Figure 2.8C) represents the 
concentration of TM-β-CD at which sample overloading is present.  Although the correlation 
using X-reciprocal method (Figure 2.8A) was only moderate, the high degree of correlation 
obtained by Y-reciprocal and double-reciprocal plots (Figure 2.8B and 2.8C, respectively) 
suggests that 1:1 complexation model is acceptable [15].   
The binding constants (i.e., K1) values between TM-β-CD and L-UCLB are listed in 
Table 2.3.  The deviations of K1 values were from the errors of different plotting methods [15].  
The non-linear isotherm plot of L-UCLB mobility is shown in Figure 2.8D.  As shown in 
Figure 2.8D, the corrected effective mobility of L-UCLB reached a plateau when the CE buffer 
contained more than 10 mM of TM-β-CD.  The value of K1 calculated was 1093 M-1 ± 123, 
which is consistent with the values obtained from the linear plotting methods.  In general, the 
value of K1 obtained in Table 2.3 was around 1000 M-1, which is comparable with the binding 
constants between TM-β-CD and imidazole based ILs [7].  These reported K1 values implied 
that TM-β-CD and L-UCLB have relatively high interaction with each other.   
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2.3.2.2 Determination of profen/TM-B-CD binding constant K2 
 The second step was to measure the binding constants of one representative PROF 
(fenoprofen) to TM-β-CD.  This experiment was conducted together with the experiments to 
measure the binding constant of fenoprofen to L-UCLB.  In other words, the measurements of 
K2 and Ki were achieved in one series of experiments by double-reciprocal plotting method.  
The TM-β-CD concentration in the CE buffers ranged from 1.0 mM to 50.0 mM.  Note that in 
Figure 2.9A and 2.9B, the linear plot in the absence of L-UCLB (i.e., 0.0 mM L-UCLB) has the 
smallest slope compared to the other linear plots in the presence of various concentration of L-
UCLB.  In other words, the slopes of the linear plots in Figure 2.9 increased as the 
concentration of L-UCLB increased.  Because K2 is obtained from the ratio of slope/intercept, 
therefore, the values of K2 decreased with the increasing concentration of L-UCLB in the CE 
buffer.  The values of K2 were calculated from these linear regression plots and are shown in 
Table 2.4.  For the R-fenoprofen, the K2 decreased from 598±26 M-1 to 198±22 M-1 upon 
increasing the concentration of L-UCLB up to 0.8 mM, and then slightly increased to 215±19 M-
1 when the concentration of L-UCLB is further increased 1.0 mM.  For the S-fenoprofen, the K2 
decreased from 625±22 M-1 to 207±24 M-1 and then increased slightly to 226±21 M-1.  The 
abnormal increase of K2 upon increasing L-UCLB from 0.8 mM to 1.0 mM is probably caused 
by the experimental errors that will be explained in the following section (i.e., section 3.2.3).  
Nevertheless, for both enantiomers, the minimal K2 values showed at 0.8 mM L-UCLB.  This 
trend implied that the L-UCLB in the buffer interacted with fenoprofen, which in turn reduced 
the affinity between fenoprofen and TM-β-CD.  The increasing amount of L-UCLB in the 
buffer will cause the decreasing affinity between fenoprofen and TM-β-CD.   
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2.3.2.3 Determination of profen/L-UCLB binding constant Ki 
The third step was to estimate the binding constants of fenoprofen to L-UCLB.  We 
respectively added L-UCLB into the 5.0 mM NaOAc buffer at concentrations of 0.0, 0.2, 0.5, 
0.8, and 1.0 mM, which were considered as the concentration of inhibitors, L-UCLB.  Next, the 
double-reciprocal plots were generated at each fixed concentration of L-UCLB.  Figure 2.9A 
and 2.9B showed the patterns of double-reciprocal plots for R- and S-fenoprofen, respectively.  
The R-squared values of these lines were better than the one for the binding between TM-β-CD 
and L-UCLB, because 10 kV was applied instead of 20 kV.  Table 2.5 listed the values of 
slopes and intercepts of these linear regression plots.  For the R-fenoprofen (columns 2 and 3), 
the slope values changed from 13.4±0.5 to 37.0±1.6, while the y-intercept values range from 
7134±696 to 8392±155.  The %RSD of the y-intercept values is about 6.0%.  In Figure 2.9, 
the error bars on the data points were removed for clarity of presentation.  The 95% confidence 
interval (95%CI) of the data point in double reciprocal plot at a fixed concentration of 1.0 mM 
TM-β-CD but variable concentration of L-UCLB (i.e., 0.8 and 1.0 mM), were ±4820 V×s×cm-2 
and ±3961 V×s×cm-2, respectively.  These 95% CI values are much greater than the ones for 
the other data points of the respective plots.  The deviation of the intercept values (especially 
for the plot at 0.8 mM L-UCLB) were due to the inaccuracy and irreproducibility of the 
migration times of fenoprofen at low concentrations of TM-β-CD.  For example, under the 
conditions of 0.8 mM or 1.0 mM L-UCLB, and the concentrations of TM-β-CD at 0.0 or 1.0 mM 
in the CE buffers, it took more than 2 hrs for the fenoprofen peaks to elute out and caused greater 
error on the migration time than at other concentration of L-UCLB.  However, this relatively 
high deviation is acceptable in the literature of biochemistry when determining the type of 
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inhibition [26].  The data for S-fenoprofen showed the same trends for the slopes and intercepts 
with the greatest deviation at 0.8 mM L-UCLB.  As we discussed in section 3.2 and shown in 
Figure 2.9 as well as Table 2.5, we believe that the pattern of the double-reciprocal plots with 
increasing slope values but constant intercept values implies that the inhibition happened 
between L-UCLB and the (TM-β-CD)-(fenoprofen) complex is similar to the enzyme-substrate-
inhibitor systems [26], and mainly it is a type of competitive inhibition.  
The data generated in Table 2.5 can be used to obtain the inhibition constant between L-
UCLB and fenoprofen (Ki) from a secondary plot of which the x-axis is the concentration of the 
L-UCLB and y-axis is the slope values of the double-reciprocal plots obtained from Table 2.5 
[18, 26].  Here the inhibition constant is the dissociation constant of the (L-UCLB)-
(fenoprofen) complex [17, 18].  As can be seen in Figure 2.10, the value of the x-intercept of 
the linear plot was the negative value of the inhibition constant Ki [18], which was 
4.81±1.18×10-4 M for R-fenoprofen, and 4.73±1.18×10-4 M for S-fenoprofen.  However, strictly 
speaking, the inhibition constant we obtained was an apparent inhibition constant. 
 
2.3.3 The binding constant of the enantiomers 
In the experiments discussed above to determine the values of K2 and Ki, the sample used 
was the racemic mixture of fenoprofen. The separation of the racemic pair was based on the 
different binding constants between the enantiomers and the two chiral selectors TM-β-CD and 
L-UCLB.  Figure 2.11 showed the double-reciprocal plots for R- and S-fenoprofen at a fixed 
concentration of 0.5 mM L-UCLB using various concentrations of TM-β-CD ranging from 0.0 
mM to 50.0 mM.  It is clear that at low concentration (i.e., below 5 mM TM-β-CD) the 
regression trendlines for the two enantiomers overlapped, suggesting no chiral resolution.  
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When the concentration of TM-β-CD is greater than 5 mM, the y axis values of the R- and S-
fenoprofen at the same concentration of TM-β-CD deviated from each other with the increasing 
concentration of TM-β-CD.  Table 2.5 showed the K2 values for R- and S-fenoprofen at 
different concentration of L-UCLB.  The K2 values for S-fenoprofen were always greater than 
R-fenoprofen at all concentration of L-UCLB ranging from 0.0 to 1.0 mM.  This trend implied 
that the interaction between S-fenoprofen and TM-β-CD was stronger compared to the one 
between R-fenoprofen and TM-β-CD.  The addition of L-UCLB did not change this trend, but 
increase the chiral resolution, which gradually changed from no resolution to partial resolution 
and then baseline resolution.  This trend is consistent with the enantioseparation shown in 
Figure 2.3. 
 
2.4 Concluding remarks 
The simultaneous enantioseparation of five profens was achieved by the addition of L-
UCLB in the low concentration range (1.5 to 2.0 mM) in the TM-β-CD buffer.  The resolutions 
(both achiral and chiral resolutions) and migration times of the profens were very sensitive to the 
concentration of L-UCLB.  Unlike the literature report on the effects of the chain length of 
anionic surfactants, decreasing length of the hydrocarbon chain of the cationic IL surfactants did 
not show any significant influence on the chiral resolutions.  However, the migration times 
decreased as expected.  The final method permits to simultaneously resolve the enantiomers of 
the PROFs with an analysis time of 44 min.  Three batches of L-UCLB made in different 
months were tested for the simultaneous enantioseparation of PROFs under same conditions.  
The migration times, efficiencies, and resolutions of the PROFs showed little deviation, which 
implies that the batch-to-batch reproducibility of L-UCLB synthesis is satisfied for the 
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enantioseparation.  Finally, the concepts of enzymatic reactions were successfully applied to 
determine the mode of inhibition of L-UCLB.  Using fenoprofen as a model compound that 
strongly interacts with TM-β-CD, a series of double reciprocal plot showed a trend of increasing 
slope values with almost a constant intercept.  This trend is in accordance with the observation 
described in the literature [26], suggesting that the inhibition observed in chiral separation of 
PROFs is a competitive inhibition.  Future studies will be focused on the combined use of the 
same dual chiral selector (i.e., TM-β-CD and L-UCLB) for the separation of neutral compounds.   
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Table 2.1 Equations used to estimate K1 between TM-β-CD and L-UCLB. 
Plotting 
method Regression equation Calculated K1 
Nonlinear 
isotherm K [TM-β-CD]=μi μf- μiμc-ν =
μc
[TM-β-CD]1+K
[TM-β-CD]Kμf-ν
 
Nonlinear 
regression  
by software 
X-reciprocal 
μi μf-
[TM-β-CD]
ν
= K- μi μf-ν + K μf-μc
 
-slope 
Y-reciprocal μi μf-
[TM-β-CD]
ν = + K μf-μc
1[TM-β-CD]μf-μc
1
 
slope/intercept 
Double 
reciprocal μi μf-ν
= +
K μf-μc
1
[TM-β-CD] μf-μc
1 11
 
intercept/slope 
 
 
 
Table 2.2 Calculation of the mobility values and viscosity correction factors for K1. 
[TM-β-CD] 
(Mm) 
t(i)a 
(min) 
t(m)b 
(min) 
μ(f)=(1/t(i)-1/t(m))×Ld×Lt/V 
(cm2×V-1×s-1×10-4) 
t0 
(min) ν=t/t0 
0.00 
7.60 
7.68 
7.66 
12.22  
12.60  
12.64 
1.524±0.024 15.93 1.000 
 
46 
 
a) t(i): the migration time of L-UCLB. 
b) t(m): the migration time of neutral marker DMSO. 
c) t: the elution time used to calculate the viscosity correction factor.  
[TM-β-CD] 
(Mm) 
t(i)a 
(min) 
t(m)b 
(min) 
μ(i)=(1/t(i)-1/t(m))×Ld×Lt/V 
(cm2×V-1×s-1×10-4) t
c (min) ν=t/t0 
2.50 
8.16 
7.93 
7.72 
11.46   
11.10   
10.71 
1.078±0.015 16.75 1.051 
3.00 
7.50 
7.60 
7.83 
10.26   
10.50   
10.88 
1.082±0.009 16.15 1.014 
3.50 
7.52 
8.10 
8.13 
10.25   
11.35   
11.48 
1.071±0.008 16.08 1.009 
4.00 
8.04 
9.06 
9.61 
11.30   
13.39   
14.62 
1.075±0.004 15.96 1.002 
4.50 
9.22 
8.71 
9.63 
13.61   
12.61   
14.49 
1.057±0.012 15.94 1.000 
5.00 
9.15 
9.03 
9.09 
13.32   
12.99   
13.33 
1.033±0.017 16.04 1.007 
5.50 
10.00 
10.57 
9.41 
15.17   
16.42   
14.02 
1.030±0.019 16.10 1.011 
6.00 
8.63 
8.18 
8.53 
12.20   
11.41   
11.93 
1.023±0.017 16.16 1.014 
7.00 
8.30 
8.51 
8.59 
11.43   
11.92   
12.05 
1.004±0.011 16.57 1.040 
8.00 
9.04 
8.53 
9.14 
12.86   
11.87   
13.07 
0.991±0.001 16.74 1.050 
9.00 
9.02 
8.92 
9.12 
12.85   
12.62   
12.94 
0.986±0.011 16.63 1.044 
10.00 
9.04 
9.50 
10.05 
12.74   
13.89   
14.94 
0.982±0.018 16.40 1.029 
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Table 2.3 Data treatment for the plots used to estimate the binding constant K1. 
Nonlinear isotherm X reciprocal 
[TM-β-CD]  
Unit: M 
ν×μ(i)-μ(f) 
Unit: cm2×V-1×s-1×10-3 
ν×μ(i)-μ(f) 
Unit: cm2×V-1×s-1×10-3 
(ν×μ(i)-μ(f))/[TM-β-CD] 
Unit: cm2×V-1×s-1×M-1 
0.0000 0.0000 N/A N/A 
0.0025 -0.0391 -0.0391 -0.01565 
0.0030 -0.0426 -0.0426 -0.01421 
0.0035 -0.0443 -0.0443 -0.01266 
0.0040 -0.0447 -0.0447 -0.01117 
0.0045 -0.0467 -0.0467 -0.01037 
0.0050 -0.0484 -0.0484 -0.00968 
0.0055 -0.0482 -0.0482 -0.00877 
0.0060 -0.0487 -0.0487 -0.00811 
0.0070 -0.0480 -0.0480 -0.00685 
0.0080 -0.0483 -0.0483 -0.00604 
0.0090 -0.0494 -0.0494 -0.00549 
0.0100 -0.0513 -0.0513 -0.00513 
Y reciprocal Double reciprocal 
[TM-β-CD]  
Unit: M 
[TM-β-CD]/(ν×μ(i)-μ(f)) 
Unit: V×s×M×cm-2 
1/[TM-β-CD] 
Unit: M-1 
1/(ν×μ(i)-μ(f)) 
Unit: V×s×cm-2×103 
0.0025 -63.98 400 -2.559 
0.0030 -70.37 333 -2.346 
0.0035 -79.00 286 -2.257 
0.0040 -89.51 250 -2.238 
0.0045 -96.49 222 -2.144 
0.0050 -103.42 200 -2.068 
0.0055 -114.10 182 -2.075 
0.0060 -123.37 167 -2.056 
0.0070 -145.99 143 -2.086 
0.0080 -165.66 125 -2.071 
0.0090 -182.13 111 -2.024 
0.0100 -195.12 100 -1.951 
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Table 2.4 The estimated values of K1 by linear plotting methods. 
Plotting method Regression equation K1 value 
Nonlinear 
isotherm y= -0.05536x/(1+1093x) K1 = 1093±123 M
-1 
X-reciprocal y = -0.9534x-0.054 K1 = -(-0.9534±0.110×1000) = 953±110 M-1 
Y-reciprocal y = -18280x-15.51 K1 = (-18280±322)/(-15.51±1.97) = 1179±151 M-1 
Double 
reciprocal y = -17.433x-17902 K1 = (-17902±351)/(-17.433±1.537) = 1027±93 M
-1 
 
The standard deviations for non-linear regression and linear regression data were calculated by 
Origin 7.5 and MS Office Excel 2007 software, respectively. 
 
 
 
Table 2.5 The estimated values of K2 for R- and S-fenoprofen from double-reciprocal plots. 
[L-UCLB] 
  (mM) 
Slope for R 
form 
(V×s×M×cm-2) 
Intercept 
for R form 
(V×s×cm-2) 
K2 for R 
form (M-1)
Slope for S 
form 
(V×s×M×cm-2) 
Intercept 
for S form  
(V×s×cm-2) 
K2 for S 
form (M-1)
0.00 13.4±0.5 8018±173 598±26 13.1±0.4 8205±139 626±22 
0.20 17.6±0.4 8392±155 477±14 17.3±0.4 8595±138 497±14 
0.50 20.9±0.2 8162±71 391±5 20.6±0.2 8397±67 408±5 
0.80 36.0±1.9 7134±696 198±22 35.7±2.0 7394±734 207±24 
1.00 37.0±1.6 7966±614 215±19 36.6±1.8 8280±662 226±21 
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Figure 2.1 Structural formulas of ionic liquids L-UCLB and L-OCLB, and the studied aryl 
propionic acids (profens). 
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Figure 2.2 Simultaneous enantioseparation of profen (PROF) drugs in the absence (A), and 
presence (B) of L-UCLB. CE conditions: 5.00 mM NaOAc, 2.63 mM HOAc (pH 5.0) containing 
35.0 mM TM-β-CD (A), and 35.0 mM TM-β-CD, 1.5 mM L-UCLB (B). Fused silica capillary, 
64.5 cm total length and 50 μm i.d.; separation temperature 16 °C; applied voltage +30 kV; 
pressure injection: 3mbar, 8 sec. UV detection at 214 nm. 
Peaks identification: 11’= R, S–ibuprofen; 22’= R, S–fenoprofen; 33’= R, S–indoprofen; 44’= R, 
S–suprofen; 55’= R, S–ketoprofen.   
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Figure 2.3 Schematic description of the interaction system involving TM-β-CD, anionic PROFs 
(P-), and chiral cationic IL-type surfactants. 
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Figure 2.4 Effect of concentration of L-UCLB for the simultaneous enantioseparation of PROF 
drugs. All other conditions are same as described in Figure 2.2(B) except variable concentration 
of L-UCLB was used. 1.0 mM L-UCLB (A), 2.0 mM L-UCLB (B), 3.0 mM L-UCLB (C).  The 
inset plot shows the resolutions of profen drugs as a function of L-UCLB concentrations.  
 
Time (min)  
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Figure 2.5 Effect of batch-to-batch reproducibility on the simultaneous enantioseparation of 
profen drugs. 5.00 mM NaOAc, 2.63 Mm HOAc, Ph 5.0; 35.0 Mm TM-β-CD buffer, 3.00 Mm 
L-UCLB, A: batch091507, B: batch092107, C: batch102207. All other conditions are the same 
as described in Figure 2.2(B). 
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Figure 2.6 Comparison of L-UCLB and L-OCLB ionic liquids for simultaneous enantio-
separation of profen drugs.  5.00 mM NaOAc, 2.63 mM HOAc, pH 5.0; 35.0 mM TM-β-CD 
buffer; 3.0 mM L-UCLB or L-OCLB.  All other conditions are the same as described in Figure 
2.2(B).  
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Figure 2.7 The representative electropherograms used to estimate the binding constant of L-
UCLB in the sample solution and TM-β-CD in the CE buffer.  5.00 mM NaOAc, pH 5.0 buffer; 
fused silica capillary, 64.5 cm total length, 56.0 cm from inlet top to detector, and 50 μm i.d.; 
separation temperature 16 °C; applied voltage +20 kV.  Pressure injection: 50 mbar, 20 sec. A: 
0.0 mM TM-β-CD; B: 3.0 mM TM-β-CD; C: 6.0 mM TM-β-CD; D: 9.0 mM TM-β-CD.  The 
arrows pointed to the peaks of L-UCLB. 
min0 2 4 6 8 10 12 
mAU 
0 
1 
2 
3 
4 
5 
6 
min0 2 4 6 8 10 12 
mAU 
0 
1 
2 
3 
4 
min0 2 4 6 8 10 12
mAU
0 
1
2
3 
min0 2 4 6 8 10 12 
mAU 
-0.5 
0 
0.5 
1 
1.5 
2
2.5 
(A) 
(B) 
(C) 
(D) 
Time (min)  
56 
 
(A)                        (B) 
   
(C)                                    (D)   
Figure 2.8 The linearized plots (A-C) and non-linearized plot (D) used to estimate the binding 
constant K1 between TM-β-CD and L-UCLB.  Each data point is the average value of triplicate 
runs.  The error bars represent 95% confidence intervals (95% CI). 
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Figure 2.9 The double-reciprocal plots used to study the type of inhibition in TM-β-CD/L-
UCLB/profen system.  A: R-fenoprofen, B: S-fenoprofen.  CE conditions: 5 mM NaOAc, pH 
5.0 buffer; fused silica capillary, 64.5 cm total length, 56.0 cm from inlet top to detector, and 50 
μm i.d.; separation temperature 16 °C; applied voltage +10 kV.  Pressure injection: 5 mbar, 10 
sec.  Each data point is the average value of triplicate runs.  The error bars were removed for 
clarity of presentation.  The average 95% CI of the data points is ±407 V×s×cm-2 for R-
fenoprofen (A), and ±424 V×s×cm-2 for S-fenoprofen (B). 
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Figure 2.10 The secondary plot used to estimate the apparent inhibition constant Ki.  The y-axis 
was the slope values of the double-reciprocal plots obtained from Figure 2.9. A: R-fenoprofen, 
B: S-fenoprofen.  The x-intercepts marked with circles represent the negative values of Ki for 
the two enantiomers.   
 
 
(A) 
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-Ki = -0.000481 
-Ki = -0.000473 
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Figure 2.11 The comparison of double-reciprocal plots for the K2 calculation of R- and S-
fenoprofen in the presence of 0.5 mM L-UCLB.  A: R-fenoprofen, B: S-fenoprofen.  Each data 
point is the average value of triplicate runs.  The error bars were removed for clarity of 
presentation.  The average 95% CI of the data points is ±228 V×s×cm-2 for R-fenoprofen (A), 
and ±229 V×s×cm-2 for S-fenoprofen (B). 
 
 
 
 
(A)
(B) 
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CHAPTER 3. A HIGH THROUGHPUT MULTIVARIATE OPTIMIZATION FOR THE 
SIMULTANEOUS ENANTIOSEPARATION AND DETECTION OF BARBITURATES IN 
MEKC-MS 
3.1 Introduction 
The chirality of a pharmaceutical drug has gained significant attention in both clinical 
and pharmaceutical settings due to the different biological activity of the two optical isomers 
(R/S or D/L enantiomers).  Barbiturates (mephobarbital, pentobarbital, and secobarbital, Figure 
3.1) are widely used in pharmaceutical applications as central nervous system (CNS) 
depressants, and they produce a broad range of effects from mild sedation to anesthesia [1].  
They are also effective as hypnotic drugs and as anticonvulsants.  Previous studies have shown 
that stereoselective effects are qualitatively similar for those of racemic barbiturates [1].  In 
contrast, later research showed that different enantiomers of barbiturates have different 
biological effects [2-5].  For example, the (S)-isomers of pentobarbital and secobarbital are 
more potent than the (R)-isomers [2, 4].  Moreover, in case of mephobarbital, it is reported that 
the hydroxylation in human liver microsomes is preferential for (R)-isomer than (S)-isomer [5]. 
The enantioselective separation of barbiturates has been carried out by various separation 
techniques.  In case of capillary GC, a thermostable chiral polymer, XE-60-L-valine-(R)-α-
phenylethylamide, was used as stationary phase to separate racemic mephobarbital [6].  A 
modified β-cyclodextrin (CD) was utilized to coat the capillary GC column for the 
enantioseparation of N-alkylated barbiturates [7].  Enantioseparation have been performed in 
HPLC incorporating chiral selectors either in the mobile phase or as a stationary phase.  The 
CD and its derivatives were used as additive in the mobile phase for the enantioseparation of 
mephobarbital and secobarbital [8-10].  In addition, various HPLC chiral stationary phases such 
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as: 3-(1,8-naphthalimido) propyl-modified silyl silica gel, cellulose tris (4-methylbenzoate), 
permethylated β-CD bonded to silica, cellulose tris (3,5-dimethylphenylcarabamate) and amylase 
3,5-dimethylphenyl-carabamate immobilized on silica have also been used to separate 
mephobarbital, pentobarbital, secobarbital, and other N-alkylated barbiturates [11-15].  
However, both GC and HPLC techniques have drawbacks concerning the high cost of the chiral 
column and the use of large amount of chiral selectors, thereby increasing the expense of 
analysis.  In addition, the efficiencies of the enantioseparation are often low, requiring the use 
of longer columns.   
Enantioseparation by CE has emerged as a powerful analytical-scale technique over the 
past decade. Some of the key advantages of CE include high efficiency, short analysis time as 
well minimal consumption of exotic and expensive chiral selectors, therefore reducing the 
operation cost.  Another advantage of using CE for chiral separation is the ability to use 
multitude of selectors, which not only provides variable selectivities but often reverse 
enantiomeric elution order.  Thus, the latter advantage of CE provides an automated approach 
with great ease for the development of chiral assays of various classes of pharmaceuticals.   
The enantioseparation of barbiturates in CE have been reported using CD and its 
derivatives as chiral selectors [16-19].  A polymeric chiral surfactant poly sodium N-
undecenoxyl-D-valinate (poly-D-SUV) has been utilized in MEKC and MEEKC to separate 
pentobarbital and secobarbital [20].  However, the low sensitivity and poor selectivity of the 
UV detection in CE have prompted the development of MS as end-capillary detection method.  
Recently, packed column capillary electrochromatography (CEC) using a permethyl-β-CD-silica 
as the stationary phase has been coupled to coordination ion spray-mass spectrometry (CIS-MS) 
for the on-line enantioseparation and detection of mephobarbital [21].  In a different study, the 
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noncovalent interactions between CD derivatives and barbiturates have been investigated by CE 
(as solution phase complexes) and by ESI-MS (as gas phase complexes) but not for on-line CE-
MS [22].   
The development of CE-MS for chiral analysis has enormous potential but the poor 
volatility and background noise generated by the low molecular weight chiral selectors (e. g., CD 
and its derivatives, macrocyclic antibiotics, and unpolymerized chiral micelles) are the main 
limitations.  To overcome these limitations, one possible alternative proposed by our research 
group involves the use of high molecular weight chiral selectors (i. e., the molecular micelles or 
polymeric surfactant) [23].  Several of our recent publications have shown that the use of chiral 
molecular micelles in MEKC-MS appears as one of the most promising approaches for 
simultaneous chiral analysis [24-25].  Notably, the addition of chiral molecular micelle in the 
MEKC buffer confers high resolving power and a wide chiral window for the simultaneous 
enantioseparation of structurally similar drugs, thereby increases the throughput.  Moreover, by 
operating the instrument in selective ion monitoring (SIM) or group SIM mode, MS provides a 
significant improvement in signal-to-noise (S/N) ratio.  These features of MS improve the limit 
of detection (LOD) for the barbiturates, thereby providing a potential approach for the analysis 
of barbiturates in biological samples (e. g., in human blood and urine).   
In this work, simultaneous enantioseparation and detection of three barbiturates 
(mephobarbital, pentobarbital, and secobarbital) is discussed using MEKC-ESI-MS enabling the 
development of a high-throughput method with high efficiency and sensitivity.  The key to 
achieve a successful simultaneous enantioseparation of these three barbiturates was to carefully 
screen various polymeric chiral surfactants.  Hence, after screening a multitude of molecular 
micelles, the use of polysodium N-undecenoxy-L-isoleucinate (poly-L-SUCIL) as chiral selector 
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and response surface methodology is proposed.  The RSM is a multivariate approach often used 
to optimize the multiple parameters in CE [26-28].   A three-factor (pH, poly-L-SUCIL 
concentration, NH4OAc concentration) full factorial central composite design (CCD) experiment 
was carried out to obtain the MEKC response for chiral resolution and migration time.  Next, a 
two factors (%methanol and NH4OH concentration) CCD experiment was conducted for the 
sheath liquid condition optimization to predict the best S/N ratio for the ESI-MS detection.   
The drying gas temperature (DGT) and drying gas flowrate (DGF) were studied using the same 
multivariate approach to highlight the significance of these two spray chamber parameters on 
MS response.  Finally, the adequacy of the developed MEKC-MS method was validated by 
experimental runs at the predicted optimized conditions.  Significantly improve S/N ratio by 
MEKC-MS and consequently better LOD were achieved compared to MEKC-UV under 
identical conditions, demonstrating the potential for the application of this powerful technique in 
the fields of pharmaceutical and biomedical analysis.   
 
3.2 Experimental 
3.2.1 MEKC-ESI-MS instrumentation 
All MEKC-ESI-MS experiments were performed on an Agilent Capillary Electrophoresis 
system (Agilent Technologies, Palo Alto, CA, USA) interfaced to a single quadrupole mass 
spectrometer, Agilent 1100 series MSD.  A G1603A CE-MS adapter kit and a G1607 CE-ESI-
MS sprayer kit (all provided from Agilent Technologies) were used to couple the CE instrument 
to MS.  The sheath liquid used in ESI spray chamber was delivered by an Agilent 1100 series 
HPLC pump equipped with a 1:100 splitter.  The temperature control of the sample carousel at 
20 °C was maintained by Fisher ISOTEMP 3016S refrigerating circulator (Fisher Scientific, 
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Pittsburgh, PA, USA).  The instrumental control, data acquisition, and data analysis were 
carried out by Agilent Chemstation and CE-MS add-on software.  The fused silica capillaries 
(Polymicro Technologies, Phoenix, AZ, USA) with dimensions of 125.0 cm total length (60.0 
cm length from inlet to UV-detection interface) 50 μm i.d., and 365 μm o.d. were used 
throughout the study.   
 
3.2.2 Reagents and Chemicals 
Mephobarbital, pentobarbital, secobarbital, and ammonium acetate (as 7.5 M aqueous 
solution) were purchased from Sigma-Aldrich (St. Louis, MO, USA).  Ammonium hydroxide 
was purchased from EM science (Gibbstown, NJ, USA).  Acetonitrile (ACN), methanol 
(MeOH), dichloromethane, ethyl acetate, 2-propanol, and acetone were purchased from Caledon 
Laboratories (Georgetown, ON, Canada).  Deionized water was prepared with a Barnstead 
“NANOpure” ultrapure water system (Dubuque, Iowa, USA).  
The reagents ω-undecylenyl alcohol, pyridine anhydrous, L-isoleucine, and other amino 
acids used for the synthesis of polymeric surfactants were purchased from Sigma-Aldrich (St. 
Louis, MO, USA).  Triphosgene was obtained from TCI (Tokyo Kasei Kogyo Co. LTD, Tokyo, 
Japan).  Hydrochloric acid and sodium sulfate anhydrous were purchased from EMD Chemicals 
(Gibbstown, NJ, USA).  Sodium hydroxide (50% w/w) was purchased from Fisher Scientific 
(Pittsburgh, PA, USA).  Sodium carbonate was purchased from Acros Organics (Geel, 
Belgium).  The polymeric surfactant, poly-L-SUCIL was synthesized following a previously 
optimized procedure [29-30]. 
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3.2.3 MEKC-ESI-MS conditions 
The concentration of each barbiturate stock solution prepared in pure ACN was 0.5 
mg/mL.  To prepare a mixture sample of three barbiturates, a fixed aliquot of mephobarbital, 
pentobarbital, and secobarbital were dissolved in the binary solvent of ACN and H2O in a ratio 
of 80:20 (v:v).  The final concentration of each barbiturate in the mixture was 125 µg/mL.  
The ammonium acetate solution was prepared by diluting 7.5 M NH4OAc aqueous solution in 
triply deionized water.  The pH of the buffer was adjusted to a required value using 1.0 M 
ammonium hydroxide.  The polymeric surfactants were individually dissolved in the 
ammonium acetate buffer. 
A bare fused silica capillary was first preconditioned for 60 minutes with 1 M NH4OH at 
50 °C, and then flushed for 30 min with triply deionized water at 20 °C.  Before each injection, 
the capillary was flushed with the separation buffer for 5 min.  After each run, the capillary was 
postconditioned with deionized water for 5 min, 0.1 M aqueous NH4OH solution for 5 min, and 
deionized water for 5 min.  The sample was hydrodynamically injected at 3 mbar for 8 seconds.  
The separations were carried out under an applied voltage of +25 kV and a temperature of 20 °C.  
The absorbance of barbiturates in the MEKC buffer was simultaneously monitored by UV 
detection at 214 nm.  The MS detection was set to negative ion in the group-SIM mode at m/z 
225, 237, and 245 to monitor the [M-H]- ions of pentobarbital, secobarbital and mephobarbital, 
respectively.  The MEKC-ESI-MS conditions, which include MEKC conditions (pH, poly-L-
SUCIL concentration, and NH4OAc concentration), the sheath liquids composition (MeOH/H2O 
ratio, concentration of NH4OAc or NH4OH), and spray chamber parameters (i. e., DGF and DGT) 
were optimized using multivariate CCD discussed in section 2.5. 
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3.2.4 Preliminary experiments 
The preliminary experiments were first conducted to screen the significant factors that 
influence the enantioseparation and S/N.  For the MEKC conditions, these factors include the 
concentration of BGE (ammonium acetate), different types of surfactants used to form micelles, 
ratio of surfactants in the mixed micelles, and ratio of organic solvent (ACN) in the aqueous 
buffer.  For the ESI-MS sheath liquid conditions, the composition of MeOH/H2O in mM 
concentration of NH4OAc vs. NH4OH were compared as additive to the sheath liquid.  For ESI 
spray chamber conditions, these factors include the DGF, DGT, and nebulizer pressure (NP).  
The use of mixed micelles and organic modifiers in the CE buffer were also studied, although 
their effects were not very significant.  These preliminary experiments were conducted before 
the multivariate approaches so that the factors explored in multivariate approaches can be 
narrowed to the effective ranges.   
 
3.2.5 The multivariate optimization approach 
 The response surface method used in this work is a CCD experimental design, which was 
accomplished by the Design-Expert (version 7.0, Stat-Ease, MN, USA) software.  In response 
surface methodology, CCD is a second-order design used to fit a second-order model, which can 
be described by the equation below [31]: 
 
In the Design-Expert software, Yx,t is called the response, x is called the factor, β0, βi, βii, and βij 
are called coefficients for the intercept, the factors, and the interaction between two factors, the 
εx,t is called residual.  In this quadratic model, the zero order term is the intercept, the first order 
terms are the βi xi terms, and the second order terms are βii xi2 and βij xixj terms.  When the x2 
(Equation 3.1) 
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terms are absent, the model is called a 2-factor interactions (2FI) model.  When all of the 
second order terms are absent, the model is regressed to a linear model.  The CCD model 
design can be described as follow [31]: 
 
The filled circles represent the center point and factorial points, while the empty circles represent 
the axial points.  The p here represents the number of factors investigated in the experimental 
design.  If there are p factors, there are 2p distinct axial points, one center point, and 2p factorial 
points [31].  For example, if there are two factors, then the CCD design need at least four 
factorial points, four axial points, and one center point.  Similarly, if there are three factors, 
then the CCD design need at least eight factorial points, six axial points, and one center point.  
However, when the model is designed, replicates of some points are usually required to improve 
the result of lack of Fit test, which is the variation of the data around the fitted model.  After the 
experimental responses are obtained, the fitness of a model was determined by the F-test and 
Lack of Fit test based on the experimental data.  For example, when the value of Prob>F for the 
F-test is less than 0.05, the model has a significant effect on the response.  On the other hand, 
for the Lack of Fit test, a value of Prob>F less than 0.05 means that the model does not fit the 
data well.  Other criteria to show the fitness of the model are the R2, adjusted R2, and predicted 
R2.  The R2 is the correlation coefficient that measures the amount of variation around the mean 
explained by the model.  The adjusted R2 is the R2 adjusted for the number of terms in the 
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model relative to the number of points in the design.  The predicted R2 is a measure of how 
good the model predicts a response value, based on the amount of variation in new data 
explained by the model.  The adjusted R2 and predicted R2 should be within approximately 0.20 
of each other.  Otherwise, there may be a problem with either data or the model.  However, a 
low R2 only does not always mean an unfitted model because the F-test is more important in the 
experimental design. 
 
3.3 Results and discussions  
The general structure of barbiturates (Figure 3.1) shows that the molecule contains a 
balance of hydrophilic and lipophilic functionality.  The hydrophilicity (polarity) is contributed 
by 2, 4, 6-pyrimidine trione ring structure, which is a function of number of N-substitutes and the 
pKa of the acidic proton(s).  On the other hand, the overall size and structure of the two alkyl 
substitutes at the 5-position exhibit non-polar characteristic.  In addition, due to the presence of 
one or more acidic protons, barbiturates can be easily converted to water soluble salts.  
Furthermore, note that the chiral center of mephobarbital is located at the 5-position of the 2, 4, 
6-pyrimidine trione ring, while the chiral centers of pentobarbital and secobarbital are located in 
a side chain outside the ring at the methylbutyl substitution.   
As barbiturates are acidic in nature, a sheath liquid of 80% MeOH and 20% H2O 
containing 5 mM NH4OAc was used and the direct infusion experiments were performed in 
negative ion mode of ESI-MS.  In the ESI-MS of each barbiturate (Figure 3.2), the highest 
intensity masses correspond to the deprotonated molecular ion [M-H]- at m/z ratios of 225, 237, 
and 245 for pentobarbital, secobarbital, and mephobarbital, respectively.  Therefore, under on-
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line MEKC-MS conditions, a group SIM was set-up to simultaneously monitor all the 
aforementioned barbiturates as [M-H]- ion in the negative ion mode.   
 
3.3.1 Preliminary experiments 
A series of polymeric surfactants were first screened by varying the type and ratio of the 
surfactants used to form molecular micelles and mixed micelles, respectively.  The polymeric 
surfactants with different head groups including poly-L-SUCIL, polysodium N-
undecenoxycarbonyl-L-leucinate (poly-L-SUCL), polysodium N-undecenoxyl carbonyl-L-
valinate (poly-L-SUCV), polysodium N-undecenoxycarbonyl-L-leucine sulfate (poly-L-
SUCLS), polysodium N-undecenoxycarbonyl-L-valine sulfate (poly-L-SUCVS), polysodium N-
undecenoxycarbonyl-L-leucyl valinate (poly-L-SULV), and polysodium N-undecenoxycarbonyl-
L-penicillamine (poly-L-SUPA) were compared.  In addition, one eight carbon chain polymeric 
surfactant, polysodium N-octenoxycarbonyl-L-leucinate (poly-L-SOcCL) and several mixed 
micelles in 1:1 ratio of poly-L-SUCL/poly-L-SUCIL, poly-L-SUVL/poly-L-SUCIL, and poly-L-
SUPA/poly-L-SUCIL were also compared.  All of these polymeric surfactants were dissolved 
in the CE buffer at the same equivalent molar concentration (EMC), which is the concentration 
of the polymeric surfactant that is equivalent to the equal weight of the same monomeric 
surfactant.  As seen in Figure 3.3 A and C, under the same experimental conditions, poly-L-
SUCL and poly-L-SUCV partially resolved three barbiturates, Furthermore, two additional 
polymeric surfactants poly-L-SULV (Figure 3.3G) and poly-L-SUPA (Figure 3.3H) provided 
partially resolution of only two of the three racemic barbiturates.  However, other polymeric 
surfactants (Figure 3.3D-F) did not resolve any of the barbiturates.  While the mixed micelles of 
poly-L-SUCL/poly-L-SUCIL, poly-L-SUVL/poly-L-SUCIL, and poly-L-SUPA/poly-L-SUCIL 
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(Figure 3.3I-K) did improve the chiral resolutions of these three barbiturates but again partially 
resolution was observed.  Nevertheless, poly-L-SUCIL was the only polymeric chiral 
surfactant, which provided baseline resolutions for all of the three barbiturates with highest 
resolution and shortest analysis time (Figure 3.3B).  
The effect of organic additive (ACN) in the buffer was also investigated by changing the 
ACN/H2O ratio in the buffer solution from 10% to 50% (v:v).  However, the addition of ACN 
in the buffer did not shorten the migration time or improve the chiral resolution of the three 
barbiturates (data not shown).  Therefore, the use of poly-L-SUCIL without any organic 
modifier was utilized for further optimization of MEKC parameters.  
Before using the multivariate CCD experiment for the optimization of MEKC conditions, 
the sequential preliminary experiments were carried out to determine which factors are important 
for the enantioseparation and what ranges of these factors needs to be further investigated in the 
CCD.  Hence, a fairly wide range was explored for the following factors: the buffer pH, EMC 
of polymeric surfactants, and concentration of BGE (NH4OAc).  The effect of buffer pH from 
7.0 to 8.0 was investigated.  The pH lower than 7.0 was not studied because these three 
barbiturates will be all neutralized at the pH lower than their pKa.  On the other hand, pH 
higher than 8.0 was found not good for the enantioselectivity.  The concentration range of poly-
L-SUCIL determined by the preliminary experiments suggests that concentration lower than 20 
mM EMC usually does not provide enough enantioresolution, while higher concentration (>50 
mM EMC) causes significant suppression of ESI-MS signal.  The concentration of NH4OAc 
used as BGE ranged from 25 mM to 40 mM.  When NH4OAc concentration was too low, the 
buffer pH was not well maintained, resulting in irreproducible retention times, whereas too high 
of NH4OAc concentration (>40 mM) causes suppression of MS signal.  The optimum 
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conditions determined by univariate approach for enantioseparation of these three barbiturates 
were as follows: pH 7.2, 50.0 mM poly-L-SUCIL, and 35.0 mM NH4OAC.   
The second step was to determine a suitable range for the sheath liquid composition to 
improve the MS sensitivity.  The sheath liquid used in MEKC optimization was a binary 
solvent of MeOH and H2O in a ratio of 80:20 (v:v) containing NH4OAc or NH4OH.  The S/N 
ratios were compared at the same concentrations of NH4OAc and NH4OH (Figure 3.4).  Two 
important trends are worth mentioning.  First, the average S/N ratios (S/N)avg were always the 
greatest at 5.00 mM using both NH4OAc and NH4OH. Second, the NH4OH achieved better 
(S/N)avg than NH4OAc in the low concentration range of 5 to 20 mM.  This second trend shows 
that the use of basic sheath liquid can improve the ionization of barbiturates when ESI negative 
mode is used.  However, at higher concentration (e. g., 50 mM NH4OAc or 50 mM NH4OH), 
(S/N)avg decreased significantly, mainly because of an increase in peak-to-peak noise and 
unstable baseline (the suppression effect of sheath liquid additives).  The ratio of MeOH and 
H2O in the sheath liquid was also investigated in the range from 20% to 80% MeOH containing 
5.00 mM NH4OH.  When a 20% MeOH sheath liquid was used, the on-line MS signals of the 
barbiturates were very weak, whereas greater than 80% MeOH caused unstable current (lack of 
conductivity).  Therefore, for multivariate optimization the concentration of NH4OH from 5.00 
mM to 20.00 mM and %MeOH from 50% to 80% were chosen. 
The third step was to determine the range of spray chamber parameters, which include 
NP, DGF and DGT.  As shown in Figure 3.5A, initially increasing the NP from 2 to 3 psi 
provided somewhat similar (Rs)avg (calculated as average resolution value for the enantiomers).  
However, as expected, the increasing NP above 3 psi caused a suction effect, showing a gradual 
decrease in (Rs)avg (Figure 3.5A) but increase in (S/N)avg (Figure 3.5B).  Therefore, a NP of 5 
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psi was chosen as a compromise between (Rs)avg and (S/N)avg.  The ranges for DGF and DGT 
were set from 4.0 to 7.0 mL/min and from 190 to 310 °C, respectively.  These ranges were 
determined based on our previous work in which good ESI-MS stability was obtained [32]. 
 
3.3.2 The multivariate optimization of MEKC conditions and ESI-MS conditions 
3.3.2.1 CCD design 
As mentioned earlier in section 3.1, the values of factorial points used in the CCD design 
were determined by the preliminary experiments.  The software then generated the center points 
and axial points according to the CCD discussed in section 2.4; the values for high and low 
levels (level +1 and -1) were obtained from preliminary experiments as the factorial points.  
However, the center points (level 0) and axial points were calculated by software.  In this work, 
the MEKC conditions were investigated by three factors (concentration of NH4OAc, EMC of 
poly-L-SUCIL, and pH values) at three levels (Table 3.1, rows 1- 5) to obtain responses for 
chiral Rs and migration time of barbiturates.  The MeOH/H2O ratio and the concentration of 
NH4OH in the sheath liquid were used to optimize sheath liquids conditions at three levels 
(Table 3.1, rows 6-10, columns 1-3) so that highest S/N ratio can be obtained.  The flowrate and 
temperature of the drying gas were also evaluated at three levels (Table 3.1, rows 6-10, columns 
4-6).   
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3.3.2.2 Evaluation and optimization of MEKC conditions on chiral resolution and migration time 
The experimental sequence and responses for MEKC optimization are shown in Table 
3.2.  The responses Rs11’, Rs22’, Rs33’, and MigTime represent the chiral resolution of 
mephobarbital, pentobarbital, secobarbital, and the migration time of the last eluted enantiomer.  
To improve the model Lack of Fit, the center point was replicated six times and factorial points 
were repeated twice.  Therefore, this CCD design has a total number of twenty eight runs, 
including six runs for the center point, sixteen runs for factorial points, and six runs for axial 
points.  The six replicated runs at center point were run# 2, 3, 9, 16, 18, and 23.  For this 6 
replicated runs, the %RSD of the experimental responses, resolution values of the three pairs of 
enantiomers (Rs11’, Rs22’, Rs33’) and the migration time of the last eluted enantiomer 
(MigTime), were 6.6%, 11%, 11%, 5.4%, respectively, which seem reasonable.  As shown in 
Table 3.2, enantiomeric resolution varies from 0.47-1.93, 0.82-1.91, and 1.20-2.26 for 
mephobarbital, pentobarbital, and secobarbital, respectively.  In addition, the analysis (i. e., 
migration time of the last eluted enantiomer) ranged from 26.5 to 49.6 min.  Figure 3.6A and 
3.6B shows two of the representative electropherograms obtained from CCD experiments (i. e., 
run 7 and 13 in Table 3.2).  The run# 7 represents one of the worst results among all the runs 
since it showed only partial chiral Rs values for all of the three barbiturates but shortest 
migration time.  This trend is observed probably because of the lowest EMC of poly-L-SUCIL 
(5.00 mM) used in this run.  On the other hand, run# 13 demonstrates one of the best overall 
separations of these enantiomers.  This experimental point was repeated at run 4, which showed 
comparable chiral Rs values and migration time (Table 3.2).   
The regression coefficient of the coded factors obtained for the response surface models 
are shown in Table 3.3.  A positive coefficient implies a positive effect of the corresponding 
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factor to the response, and vice versa.  The term with greater coefficient has more effect on the 
response.  For example, the EMC of poly-L-SUCIL (factor B in Table 3.3) has a coefficient of 
0.37 for Rs11’, the greatest among all of the coefficients (in column 2, Table 3.3), which implies 
that the EMC of poly-L-SUCIL has the most effect on the chiral Rs of mephobarbital, and the 
value of chiral Rs will increase with the increase of the EMC of poly-L-SUCIL.  On the other 
hand, the pH (factor A in Table 3.3) has the greatest negative coefficient of -0.15 for Rs11’, 
which suggests that the pH value has the greatest negative effect on the chiral Rs of 
mephobarbital.  The value of chiral Rs will decrease with the increase of pH in the buffer.  
Note that the model for Rs11’, Rs22’, and Rs33’ are quadratic models, which have first and 
second order terms; while the model for migration time is a linear model, which has only first 
order terms.   
The probabilities of each term having an effect on the response (i. e., Prob>F) are 
summarized in Table 3.3.  A coefficient is not considered significantly different from zero if 
Prob>F is larger than 0.05.  Under such conditions, the corresponding factor is regarded as non-
critical.  A careful evaluation reveals that four terms, pH (A), [poly-SUCIL] (B), [NH4OAc] (C), 
and [poly-SUCIL]2 (B2), are significant to the resolution of mephobarbital (11’) and secobarbital 
(33’).  In addition, three terms A, B, and B2 are significant to the resolution of pentobarbital 
(22’), whereas the terms A, B, and C are significant to the migration times of the three pairs of 
enantiomers.  The R2, adjusted R2, and predicted R2 for chiral Rs of each barbiturate are also 
compared in Table 3.3.  The R2 for mephobarbital is better compared to that of pentobarbital 
and secobarbital.  One possible explanation is the shorter migration time of the mephobarbital 
enantiomers compared to other two barbiturates.  The difference between adjusted R2 and 
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predicted R2 of Rs33’ is greater than 0.20, which is also caused by the longer migration time of 
secobarbital.   
Figure 3.7 A-C shows the response surface plots of the chiral resolutions of 
mephobarbital, pentobarbital, and secobarbital as a function of [poly-L-SUCIL] versus pH, 
[poly-L-SUCIL] versus [NH4OAc], and [NH4OAc] versus pH.  The values of responses on the 
designed points (factorial points, center points, and axial points) were obtained from 
experimental data, and other response values were calculated from Equation 1 (see section 2.4) 
with the certain values of the factors and their coefficients, resulting in the 3D graphs of 
response surfaces.  In general, for all of the three pairs of enantiomers the highest chiral 
resolutions were obtained at the highest [poly-L-SUCIL], the highest [NH4OAc], and the lowest 
pH values.  These trend and the high resolution values are mainly due to the high chiral 
selectivity of poly-L-SUCIL.  On the other hand, high BGE concentration and low pH will 
decrease the EOF, thereby increasing the interaction between poly-L-SUCIL and barbiturates; 
consequently, the chiral Rs will improve. A close view of Figure 3.7 reveals that the combination 
of poly-L-SUCIL and NH4OAc concentrations (i. e., the middle 3D plot in each Figure 3.7 A, B, 
and C) influenced the chiral Rs most for all three barbiturates compared to the other two 
combinations (i. e., poly-L-SUCIL vs pH, or NH4OAc vs pH).  Moreover, in most instances 
enantioresolution is least sensitive to the change in pH because the 3D plots are fairly flat along 
the pH axis.  This is not too surprising as the absolute value of coefficient for pH is smallest 
than that of poly-L-SUCIL and NH4OAc (Table 3.3, row 5). 
In addition to chiral Rs, analysis time (i. e., migration time) of the last eluting enantiomer 
was also studied as a response (Figure 3.8).  As shown in Figure 3.8, the shortest migration 
time was always obtained at the lowest concentration of poly-L-SUCIL and NH4OAc, and at the 
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highest pH values.  The main reason of increasing migration time with poly-L-SUCIL 
concentration is that the negatively charged micelles formed by poly-L-SUCIL migrate in the 
opposite direction to cathodic EOF when using positive polarity CE.   The adsorption of 
surfactant on the capillary wall decreases the EOF and thereby also increase the migration time 
of barbiturates.  Therefore, the EMC of poly-L-SUCIL has a greatest effect on the total analysis 
time.  Similarly, NH4OAc concentration is directly related to the migration time.  The reason 
is that the high concentrations of NH4OAc as BGE cause lower EOF and longer total analysis 
time.  As mentioned earlier, increase in the pH value is inversely related to the migration time 
because the increase of pH value will increase EOF and consequently decrease the total analysis 
time.  Note that the decrease on migration time is relatively more pronounced when poly-L-
SUCIL is combined with NH4OAc (Figure 3.8B), compared to the interactive effect of pH with 
poly-L-SUCIL (Figure 3.8A) or NH4OAc (Figure 3.8C).   
 
3.3.2.3 Optimizations of ESI-MS conditions 
 The information gathered in Table 3.4 shows the experimental factors and the responses 
(S/N)avg for the optimization of sheath liquid conditions.  The center point runs were repeated 5 
times and each axial point were repeated twice.  The center point was set at run# 6, 9, 12, 16, 
and 17, among which the response of run# 12 deviated obviously from other data.  The Q test 
showed that Q(run 12) is 0.974, which is much greater than the Q99% (0.821); therefore one could 
ignore that run.  The %RSD of the repeatable four runs at center point was 1.8%.  As shown in 
Figure 3.9(A), the highest (S/N)avg was obtained at lowest [NH4OH] and highest %MeOH, which 
is 5.00 mM NH4OH and 80% MeOH.  This trend suggests that the lower molar concentration of 
NH4OH and higher volume ratio of MeOH in the sheath liquid favor the electrospray ionization 
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process, and hence the MS signals of barbiturates.  The upper half of Table 3.6 shows the 
regression coefficients for the coded factors in the models of the sheath liquid optimization.  
The model for sheath liquid is a 2FI model, which has the first order terms and the interaction 
terms (AB), but no other second order terms (i. e., A2 and B2).  The 2FI model shows a much 
better Lack of Fit value than a quadratic model, so we chose this former model for the sheath 
liquid optimization.  The concentration of NH4OH (A), volume ratio of MeOH (B), and the 
interaction between these two factors (AB) are significant to (S/N)avg.  The interaction between 
[NH4OH] and %MeOH is probably caused by the influence of MeOH on the volatility and 
conductivity of the sheath liquid, which is also affected by the NH4OH in the sheath liquid.  
The variance between adjusted R2 and predicted R2 were caused by experimental errors. 
The data in Table 3.5 shows the experimental response of the CCD design for spray 
chamber optimization.  The center point was repeated five times and each factorial point was 
repeated twice.  The %RSD of the runs for center point at run# 2, 6, 9, 11, and 12 is 13%.  As 
seen in Figure 3.9(B), the maximum (S/N)avg was obtained at lowest DGF and highest DGT, 
which is the setting of 4.0 mL/min and 310 °C, respectively.  As shown in lower half of Table 
3.6, the model for spray chamber is a quadratic model.  The terms of DGF (C), and C2 are 
significant to the response (S/N)avg with the Prob>F values of 0.0002 and 0.0314, respectively.  
The DGT (D) and D2 are not significant individually but the interaction between DGT and DGF 
(CD) is a significant term with Prob>F value of 0.0302 for the S/N ratio.  Again, the variance 
between adjusted R2 and predicted R2 is most probably caused by the experimental errors. 
The ANOVA shown in Table 3.7 implies that the quadratic models generated for the 
three barbiturate enantiomers (i.e., Rs11’, Rs22’, Rs33’) and migration time are all significant to 
their responses because the F test of the model are all less than 0.05.  The Lack of Fit tests of 
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the quadratic models for the chiral resolutions are not significant, which indicates that the 
models fit the experimental data.  The Lack of Fit test of the linear model for MigTime is 
significant, and changing the model to a higher order did not improve the lack of Fit test.  
However, the R2 for the model of MigTime is better than the R2 for Rs22’ and Rs33’ (Table 3.3).  
Therefore, we still use this linear model for the optimization of migration time.  The model for 
sheath liquid optimization and spray chamber optimization are both significant to the response of 
(S/N)avg since their F tests are both less than 0.05.  The Lack of Fit test of the model for (S/N)avg 
by optimizing the sheath liquid parameters is not significant, although the R2 is relatively low 
(Table 3.6).  The Lack of Fit test for spray chamber optimization is not significant, and its R2 is 
better than the one for sheath liquid optimization (Table 3.6).  Therefore, we think that the 
models designed for both sheath liquid and spray chamber optimization fit the data, and use them 
to predict the optimum conditions.   
As shown in Table 3.7, the value of F-ratio for the model of chiral resolution of 
mephobarbital (66.5) is much greater than pentobarbital and secobarbital (Rs22’ and Rs33’), and 
the model for chiral resolution of secobarbital has the smallest F-ratio (3.40) compared to the 
other two barbiturates.  This decrease of F-ratio values causes the increase of F-test values from 
<0.0001 to 0.0131 for these three models, which implies that the significance of the models 
generated for the chiral resolution is increasing.  We believe that the earliest eluted 
mephobarbital was measured most accurately and caused the least experimental error.  
However, the latter two barbiturates eluded longer and caused greater variations on the migration 
time.  It is the same reason that causes lower R2 of the latter two models.  The values of Lack 
of Fit test for these three models increase from mephobarbital to secobarbital according to their 
elution order, which implies that the quadratic model for the chiral resolution of secobarbital fits 
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the experimental data best, and the quadratic model for mephobarbital fits worst.  This trend is 
reversed compared to the F-test values of these three models.  The reason is probably that the 
quadratic model for chiral resolution of secobarbital fit the experimental data better than other 
type of models (i.e., linear or 2FI model) although the experimental data for this model are more 
deviated.   
 
3.3.2.4 Final optimum conditions and validation studies 
The final overall optimum experimental conditions and three representative 
electropherograms are shown in Figure 3.10.  For the optimization of MEKC conditions, the 
highest resolution values for the three barbiturates and the shortest total analysis time were set as 
the criteria for a desirability function shown below, which calculated the geometric mean of all 
responses obtained in the optimization.  
 
where D is the desirability ranging from 0 (the least desirable) to 1 (the most desirable), di is the 
response (i. e., three chiral resolution values of the barbiturates and the total migration time), n is 
the number of responses (three in the MEKC optimization).  The calculation procedure was 
conducted by the DOE software to obtain the highest possible D value.  The optimizations of 
S/N ratio for the sheath liquid and the spray chamber conditions were obtained by similar 
approaches.  Consequently, the final overall optimization was the combination of the three 
optimizations: MEKC conditions, sheath liquid composition, and spray chamber parameters.  
After setting-up a requirement to achieve good trade-off between the chiral resolution and 
migration time, the optimum MEKC conditions generated by software were 25.00 mM NH4OAc, 
pH 7.00, and 39.7 mM poly-L-SUCIL. The optimum (S/N)avg was obtained at the following ESI-
(Equation 3.2) 
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MS conditions.  The sheath liquid composition is 5 mM NH4OH in the binary solvent of MeOH 
and H2O in a ratio of 80:20 (v:v).  The spray chamber parameters are a NP value of 5 psi, 4.0 
mL/min DGF, and 310 °C DGT.   
The generated optimized condition was then validated experimentally by a representative 
series of replicate (n=3) electropherogram (Figure 3.10) of three barbiturates under these 
conditions, the experimental resolution values are slightly lower than the predicted ones (Figure 
3.10 inset table), with the percent discrepancy of 20%, 13%, and 15% for mephobarbital, 
pentobarbital, and secobarbital, respectively.  However, the percent discrepancy of the total 
analysis time is slightly shorter (13% difference) and the (S/N)avg slightly higher (3% difference) 
compared to the predicted values. 
 
3.3.2.5 The determination of LOD 
The MS detector provides much better sensitivity than the UV detector.  Figure 3.11A 
and B shows the S/N ratio for UV and MS signals from the same experiment (using the same 
capillary) under the optimum MEKC-ESI-MS conditions.  When the concentration of each 
racemic barbiturate was 125 µg/mL, the S/N ratio of the MS detection was three folds higher 
than UV detection for mephobarbital, and at least five times higher than UV detection for 
pentobarbital and secobarbital (Figure 3.11A and B).  When the ESI-MS detector reached its 
LOD, the concentration of each barbiturate was 7.8 µg/mL (Figure 3.11C).  At high 
concentration (e. g., 125 µg/mL, Figure 3.11B), the MS S/N ratio of mephobarbital enantiomers 
are higher than pentobarbital and secobarbital.  However, S/N ratios of three barbiturates are 
very close at the LOD (Figure 3.11C).  The standard plots were made to calibrate the peak area 
values of these three barbiturates for the MS detection (Figure 3.12A-C).  The peak area values 
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shown in this figure are the average values of the two racemic enantiomers.  The concentration 
of barbiturates was tested from 125 µg/mL to 7.8 µg/mL, in the range of LOD.  As shown in 
Figure 3.12, all three barbiturates can be quantitated even at 7.8 µg/mL, although the linear 
correlation coefficient for mephobarbital (R2 in Figure 3.12 A) is slightly lower than the other 
two barbiturates (R2 in Figure 3.12 B and C).   
 
3.4 Conclusions  
The present studies illustrate the effectiveness of MECK-ESI-MS technique for the 
optimization of enantioseparation and detection of three barbiturates.  The simultaneous 
enantioseparation of all three barbiturates was achieved in a single run under 32 min using a 
polymeric surfactant poly-L-SUCIL.  A three-factor three-level CCD experimental design was 
used to optimize the MEKC conditions.  The EMC of poly-L-SUCIL and concentration of 
NH4OAc are the two most significant factors to the chiral resolution and migration time of 
mephobarbital and secobarbital.  On the other hand, the pH values and EMC of poly-L-SUCIL 
are significant factors to the chiral resolution of pentobarbital.  The optimum separation 
conditions were determined from the CCD model to obtain the highest overall chiral resolution 
and shortest analysis time.  Similarly, the ESI-MS sheath liquid composition and ESI spray 
chamber parameters were optimized by two-factor three-level CCD design to obtain highest 
overall S/N ratio.  For sheath liquid conditions, the concentration of NH4OH, the volume ratio 
of MeOH/H2O, and the interaction between these two factors are significant to S/N ratio.  In 
addition, spray chamber parameters, the DGF and the interaction between DGF and DGT are 
also significant to S/N ratio.   
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The final optimized MECK-ESI-MS conditions were predicted from the desirability 
function, which is based on the optimization of MEKC conditions, MS sheath liquid 
composition, and MS spray chamber parameters.  This final optimization was tested by a series 
of experimental runs and the results were in good agreement with the predicted results.  The 
LOD of these three barbiturates for MS detection was determined to be 7.8 µg/mL and was much 
more sensitive than UV detection.  The CCD experimental design proved to be an effective 
multivariate approach to optimize separation conditions and improve S/N ratio of barbiturate 
samples in MEKC-MS.  We believe that the multivariate approaches for optimization of other 
classes of chiral compound will continue to increase.  In this regard, the wider chiral window of 
molecular micelles in MEKC-MS will allow new application areas for the simultaneous analysis 
of multiple chiral drugs and their chiral metabolites.    
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Table 3.1 Levels of factors in the CCD approaches used for the multivariate optimization of 
MEKC conditions, sheath liquid conditions, and spray chamber conditions. 
MEKC conditions 
Level A: pH B: [poly-L-SUCIL] (EMC=mM) C: [NH4OAc]  (mM) 
-1 7.00 20.0 25.0 
0 7.50 35.0 32.5 
+1 8.00 50.0 40.0 
 
Sheath liquid conditions 
 
 
Spray chamber conditions 
Level A: [NH4OH] (mM) B: %MeOH  Level C: DGF (mL/min) D: DGT (°C) 
-1 5.0 50  -1 4.0 190 
0 12.5 65  0 5.5 250 
+1 20.0 80  +1 7.0 310 
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Table 3.2 Resolution and retention time data gathered from the CCD experiment for the 
optimization of separation parameters. 
Experimental factors  Experimental responses 
Run order A: pH B: [poly-L-SUCIL] (EMC=mM) 
C: [NH4OAc] 
(mM)  Rs11’ 
a Rs22’ b Rs33’ c MigTime 
d 
(min) 
1 8.00 20.00 40.00  0.7 1.1 1.4 31.0 
2 7.50 35.00 32.50  1.3 1.3 1.5 34.0 
3 7.50 35.00 32.50  1.4 1.6 1.8 34.2 
4 7.00 50.00 40.00  1.9 1.7 1.9 40.6 
5 7.50 35.00 17.50  1.4 1.5 1.8 32.9 
6 8.00 50.00 40.00  1.6 1.4 1.8 41.3 
7 7.50 5.00 32.50  0.5 0.8 1.2 26.5 
8 8.00 50.00 25.00  1.6 1.7 1.8 36.8 
9 7.50 35.00 32.50  1.4 1.8 2.0 35.7 
10 7.50 35.00 47.50  1.6 1.9 2.3 49.6 
11 7.50 65.00 32.50  1.9 1.6 1.7 44.4 
12 7.00 20.00 25.00  1.1 1.4 1.8 28.6 
13 7.00 50.00 40.00  1.9 1.9 2.1 42.8 
14 7.00 20.00 40.00  1.2 1.5 1.9 34.7 
15 7.00 20.00 25.00  1.1 1.4 1.9 29.6 
16 7.50 35.00 32.50  1.5 1.7 2.0 36.7 
17 6.50 35.00 32.50  1.7 1.8 2.0 43.8 
18 7.50 35.00 32.50  1.5 1.6 1.9 38.0 
19 7.00 50.00 25.00  1.8 1.6 1.8 43.2 
20 8.50 35.00 32.50  0.9 1.5 1.7 34.1 
21 8.00 50.00 40.00  1.8 1.7 1.8 44.8 
22 8.00 20.00 40.00  1.0 1.5 1.9 37.4 
23 7.50 35.00 32.50  1.6 1.8 2.1 38.8 
24 7.00 50.00 25.00  1.9 1.7 2.0 41.0 
25 8.00 20.00 25.00  0.8 1.3 1.6 28.4 
26 8.00 20.00 25.00  0.8 1.3 1.6 28.4 
27 7.00 20.00 40.00  1.2 1.6 2.0 34.3 
28 8.00 50.00 25.00  1.6 1.7 1.8 37.8 
 
a: mephobarbital, b: pentobarbital, c: secobarbital.   
d: the migration time of the last eluting enantiomer.   
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Table 3.3 The regression coefficients of the coded factors and ANOVA of the response surface 
models for chiral resolution and migration time.  
 Rs11’ a Rs22’ b Rs33’ c MigTime d
Model order Quadratic Quadratic Quadratic Linear 
Term Coefficient Prob>Fe Coefficient Prob>Fe Coefficient Prob>Fe Coefficient Prob>Fe
Intercept (β0) 1.45  1.64  1.89  36.76  
A: pH -0.15 <0.0001 -0.067 0.0304 -0.088 0.0193 -1.19 0.0447 
B:[poly-L-SUCIL] 0.37 <0.0001 0.16 <0.0001 0.074 0.0429 4.64 <0.0001 
C:[NH4OAc] 0.041 0.0264 0.041 0.1672 0.073 0.0450 2.78 <0.0001 
AB 0.031 0.1480 0.019 0.5961 0.029 0.4992   
AC 0.0025 0.9051 -0.044 0.2241 -0.029 0.4992   
BC -0.0038 0.8581 -0.02 0.5720 -0.014 0.7454   
A2 -0.031 0.0720 -0.0023 0.9329 -0.00047 0.9888   
B2 -0.059 0.0021 -0.11 0.0008 -0.11 0.0042   
C2 0.014 0.4113 0.013 0.6505 0.031 0.3627   
R2 0.97  0.76  0.63  0.80  
Adjusted R2 f 0.96  0.65  0.44  0.78  
Predicted R2 g 0.92  0.45  0.18  0.71  
 
a: mephobarbital, b: pentobarbital, c: secobarbital.   
d: the migration time of the last eluting enantiomer.   
e: probability of the null hypothesis being true (the factor has no significant effect on the 
response) based on the F-test of comparing model variance with residual variance.  Any term 
with P<0.05 is considered significant, and called for rejection of null hypothesis.  
f: correlation coefficient adjusted for the number of terms in the model relative to the number of 
points in the design. 
g: correlation coefficient based on the amount of variation in new data explained by the model. 
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Table 3.4 The experimental data gathered for S/N ratios from the CCD experiment for the 
optimization of sheath liquid conditions. 
Experimental parameters Experimental response 
Run order A: [NH4OAc] (mM) B: %MeOH (S/N)avg a 
1 3.58 65.00 14.6 
2 21.42 65.00 1.0 
3 12.50 47.16 5.1 
4 12.50 47.16 2.3 
5 20.00 50.00 6.8 
6 12.50 65.00 8.1 
7 20.00 80.00 6.1 
8 5.00 50.00 3.9 
9 12.50 65.00 7.9 
10 5.00 80.00 21.0 
11 12.50 82.84 3.9 
12 12.50 65.00 19.6 
13 12.50 82.84 8.3 
14 3.58 65.00 7.3 
15 21.42 65.00 1.0 
16 12.50 65.00 7.8 
17 12.50 65.00 7.8 
 
a: (S/N)avg = average S/N ratio of all six enantiomeric peaks. 
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Table 3.5 The experimental data gathered for (S/N)avg from the CCD experiment for the 
optimization of spray chamber parameters. 
Experimental parameters Experimental response 
Run order A: DGF (mL/min) a B: DGT (°C) b (S/N)avg c 
1 4.0 190 21.1 
2 5.5 250 14.9 
3 4.0 310 26.5 
4 5.5 350 10.4 
5 7.0 310 6.1 
6 5.5 250 12.0 
7 7.0 190 9.2 
8 4.0 190 22.2 
9 5.5 250 12.9 
10 7.0 190 17.8 
11 5.5 250 16.1 
12 5.5 250 16.5 
13 3.0 250 25.2 
14 7.0 310 7.2 
15 4.0 310 27.8 
16 8.0 250 15.8 
17 5.5 150 10.0 
 
a: DGF = drying gas flowrate, 
b: DGT = drying gas temperature, 
c: (S/N)avg = average S/N ratio of all six enantiomeric peaks. 
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Table 3.6 The regression coefficients of the coded factors used in the response surface models 
for the optimization of sheath liquid conditions and spray chamber parameters. 
Sheath liquid conditions 
 (S/N)avg a 
Model order 2FI 
Term Coefficient Prob>F 
Intercept (β0) 7.06  
A: [NH4OH] -3.69 0.0030 
B: %MeOH 2.29 0.0403 
AB -4.45 0.0140 
A2  
B2  
R2 0.69  
Adjusted R2 0.62  
Predicted R2 0.24  
Spray chamber parameters 
 (S/N)avg a 
Model order Quadratic 
Term Coefficient Prob>F 
Intercept (β0) 14.95  
C: DGF -5.35 0.0002 
D: DGT -0.15 0.8787 
CD -3.09 0.0302 
C2 2.46 0.0314 
D2 -1.18 0.2633 
R2 0.81  
Adjusted R2 0.73  
Predicted R2 0.35  
 
a: (S/N)avg = average S/N ratio of all six enantiomeric peaks. 
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Table 3.7 ANOVA of the CCD approaches used for the optimization of MEKC conditions, sheath 
liquid conditions and spray chamber parameters. 
Responses Source Sum of squares 
Degree of 
freedom 
Mean 
square F-ratio Porb>F 
MEKC factors 
Rs11’ a 
Model 4.10 9 0.455 66.5 <0.0001 
Residual 0.12 18 0.00684   
Corrected total 4.22 27    
p-Lack of Fit     0.3773 
Rs22’ b 
Model 1.13 9 0.126 6.53 0.0004 
Residual 0.35 18 0.0193   
Corrected total 1.48 27    
p-Lack of Fit     0.6649 
Rs33’ c 
Model 0.85 9 0.0945 3.40 0.0131 
Residual 0.50 18 0.0278   
Corrected total 1.35 27    
p-Lack of Fit     0.8344 
MigTime d 
Model 737.08 3 245.69 32.4 <0.0001 
Residual 181.98 24 7.58   
Corrected total 919.06 27    
p-Lack of Fit     0.0314 
Sheath liquid parameters 
(S/N)avg e 
Model 261.54 3 87.18 9.10 0.0020 
Residual 115.01 12 9.58   
Corrected total 376.56 15    
p-Lack of Fit     0.1230 
Spray chamber parameters 
(S/N)avg e 
Model 582.33 5 116.47 9.45 0.0011 
Residual 135.65 11 12.33   
Corrected total 717.98 16    
p-Lack of Fit     0.0530 
 
a: mephobarbital, b: pentobarbital, c: secobarbital.   
d: the migration time of the last eluting enantiomer. 
e: (S/N) avg = average S/N ratio of all six enantiomeric peaks. 
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Figure 3.1 Structure of chiral polymeric surfactant, poly-L-SUCIL, and the barbiturates.   
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Figure 3.2 Direct infusion mass spectrums of (A) mephobarbital, (B) pentobarbital, and (C) 
secobarbital.  The inset of each mass spectrum provides information on the physicochemical 
properties of barbiturates (Data from SciFinder Scholar 2008).   
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Figure 3.3 The on-line MEKC-MS of three chiral barbiturates mixture using various polymeric 
surfactants in MEKC.  Capillary 125.0 cm, ID 50 µm, 20 °C, +25 kV.  CE buffer: 25.00 mM 
NH4OAc, pH 8.0, 50.00 mM surfactant.  Barbiturates mixture: 125.0 µg/mL of each racemate 
in ACN:H2O 80:20 (v:v), injection 2 mbar, 5 sec.  Spray chamber: NP 3 psi, DGF 5.0 mL/min, 
DGT 250 °C.  Sheath liquid: 5 mM NH4OAc in MeOH:H2O 80:20 (v:v), 5 µL/min.   Pea 11’: 
mephobarbital, 22’: pentobarbital, 33’: secobarbital.  A: poly-L-SUCL, B: poly-L-SUCIL, C: 
poly-L-SUCV, D: poly-L-SUCLS, E: poly-L-SUCVS, F: poly-L-SOCL, G: poly-L-SULV, H: 
poly-L-SUPA, I: the mixed micelle of poly-L-SUCL and poly-L-SUCIL 1:1 (M:M), J: the mixed 
micelle of poly-L-SULV and poly-L-SUCIL 1:1 (M:M), K: the mixed micelle of poly-L-SUPA 
and poly-L-SUCIL 1:1 (M:M).  The numbers on the right side of the peaks in A-C and G-K 
represent the resolution values. 
 
 
 
Figure 3.4 Comparison of S/N ratios of barbiturates using different concentrations of NH4OAc 
and NH4OH in the sheath liquids of MeOH:H2O 80:20 (v:v).  The S/N ratio is the average value 
of six peaks of barbiturates enantiomers.  The error bar represents the one standard deviation of 
two measurements. 
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Figure 3.5 Comparison of chiral resolutions and S/N ratios of barbiturates as the nebulizer 
pressure changed from 2 psi to 6 psi.  The chiral resolution value is the average value obtained 
for three pairs of barbiturate enantiomers.  The S/N ratio is the average value obtained for six 
peaks of barbiturates enantiomers.  The error bar represents the one standard deviation of two 
measurements. 
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Figure 3.6 The representative MS experimental responses for the optimization of MEKC 
conditions.  Capillary 125.0 cm, ID 50 µm, 20 °C, +25 kV.  Barbiturates mixture: 125.0 
µg/mL of each racemate in ACN:H2O 80:20 (v:v), injection 2 mbar, 5 sec.  Spray chamber: NP 
3 psi, DGF 5.0 mL/min, DGT 250 °C.  Sheath liquid: 5 mM NH4OAc in MeOH:H2O 80:20 
(v:v), 5 µL/min.  The MEKC conditions for run# 7 and run# 13 are listed in Table 3.2.  Peak 
11’: mephobarbital, 22’: pentobarbital, 33’: secobarbital. 
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Figure 3.7 The response surface plot for the optimization of chiral resolutions of mephobarbital 
(A), pentobarbital (B), and secobarbital (C) as a function of [poly-L-SUCIL] versus pH (i), 
[poly-L-SUCIL] versus [NH4OAc] (ii), and [NH4OAc] versus pH (iii).  Rs11’: chiral resolution 
of mephobarbital, Rs22’: chiral resolution of pentobarbital, Rs33’: chiral resolution of 
secobarbital.   
(A) (i) (ii) (iii) 
(B) (i) (ii) (iii) 
(C) (i) (ii) (iii) 
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Figure 3.8 The response surface plots for the optimization of the migration time as a function of 
[poly-L-SUCIL] versus pH (A), [poly-L-SUCIL] versus [NH4OAc] (B), and [NH4OAc] versus 
pH (C).  The S/N ratio is the average value of six peaks of barbiturates enantiomers. 
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(A)                (B) 
Figure 3.9 The response surface plots for the optimization of sheath liquid conditions (A), and 
spray chamber parameters (B) for S/N ratio as the function of [NH4OAc] versus %MeOH.  The 
S/N ratio is the average value of six peaks of barbiturate enantiomers. 
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Figure 3.10 The electropherograms obtained under final optimum conditions of MEKC-ESI-MS.  
Capillary 125.0 cm, ID 50 µm, 20 °C, +25 kV.  25.00 mM NH4OAc, pH 7.0, 39.69 mM poly-L-
SUCIL.  Barbiturates mixture: 125.0 µg/mL of each racemate in ACN:H2O 80:20 (v:v), 
injection 2 mbar, 5 sec.  Sheath liquid: 5 mM NH4OAc in MeOH:H2O 80:20 (v:v), 5 µL/min.  
Spray chamber: NP 5 psi, DGF 4.0 mL/min, DGT 310 °C.  Peak 11’: mephobarbital, 22’: 
pentobarbital, 33’: secobarbital.  The inset table compares the predicted values with the 
experimental data. 
 
 
 Rs11’ Rs22’ Rs33’ MigTime (min) (S/N)avg 
   Predicted 1.6 1.7 1.9 36.6 24.5 
 Experimental 1.4 1.5 1.6 32.0 25.2 
 
 
Time (min) 
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Figure 3.11 The comparison of UV signal and MS signal at optimum MEKC-ESI-MS conditions.  
A and B: 125 µg/mL for each racemic barbiturate; C: 7.8 µg/mL for each racemic barbiturate.  
All other conditions are same as described in Figure 3.10.  The S/N ratios labeled are the 
average values of the two enantiomers.  Peak 11’: mephobarbital, 22’: pentobarbital, 33’: 
secobarbital. 
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Figure 3.12 The calibration plots of barbiturates for MEKC-MS quantitation.  (Peak area)avg 
are the average values of the two enantiomer peaks.  A: mephobarbital, B: pentobarbital, C: 
secobarbital.  The error bar represents one standard deviation of two measurements. 
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FUTURE DIRECTION 
 The utility of IL-type surfactants and TM-β-CD as dual chiral selector has proved to be 
successful for enantioseparation of negatively charged species.  The future direction will be 
focused on the enantioseparation of neutral species and even positively charged species.  In 
addition, the structure-enantioselectivity relationship need to be investigated on details such as 
the effects of different head groups on the surfactant molecule, the length of the hydrocarbon 
chain, and the type of CD derivatives.   
 The MEKC-ESI-MS technique is a powerful analytical tool for simultaneous enantio-
separation.  The polymeric surfactants can be used to form molecular micelles or mixed 
molecular micelles as pseudostationary phase and chiral selector.  The future step is to analyze 
the parent chiral drugs and their chiral metabolites in human blood or urine by this technique.  
On the other hand, the multivariate optimization can be used to improve the performance of 
other CE-MS techniques such as atmospheric pressure photoionization (APPI) coupled to 
MEKC-MS. 
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APPENDIX A: THE CALCULATION PROCEDURE OF EFFECTIVE MOBILITIES TO 
OBTAIN LINEAR AND NON-LINEAR PLOTS FOR THE ESTIMATION OF K1 AND K2 
The calculation procedure involves calculating the effective mobility of L-UCLB from 
the migration time of neutral marker and L-UCLB.  Next, the viscosity correction factor is 
calculated and used in the calculation of the x-axis and y-axis values for x-reciprocal plot, y-
reciprocal plot, double-reciprocal plot, and isotherm plot.  Other parameters such as total length 
of capillary (L) and effective length of capillary (l) were measured experimentally for each 
capillary used in CE instrument, and the voltage applied was 20000 V.  Therefore, the effective 
mobility is calculated by the equation of µep=L×l×(1/t(i)-1/t(m))/V.  The detailed data treatment 
for K1 is shown in Appendix B.   
Similarly, the effective mobility of fenoprofen is calculated from the migration time of 
neutral marker and R-/S-fenoprofen.  Then the x-axis and y-axis values for double-reciprocal 
plots are calculated with the viscosity correction factors to estimate K2 at different concentration 
of L-UCLB from 0.0 mM to 1.0 mM.  Other parameters such as total length of capillary (L) and 
effective length of capillary (l) were measured experimentally for each capillary used in CE 
instrument, and the voltage applied was 10000 V.  Therefore, the effective mobility is 
calculated by the equation of µep=L×l×(1/t(i)-1/t(m))/V.  The detailed data treatment for K2 can 
be found in Appendix C.  
 
 
 
 
107 
APPENDIX B: THE DETAILED DATA TREATMENT TO CALCULATE THE X-AXIS AND 
Y-AXIS VALUES OF LINEAR AND NON-LINEAR PLOTS FOR THE ESTIMATION OF K1 
   L=64.5 cm, l=56.0 cm. 
[TM-β-CD]   
(mM) 
1/[TM-β-CD] 
(M-1) t(i) (min) 1/t(i) (s
-1) t(m) (min) 1/t(m) (s-1) 1/t(i)-1/t(m)   (s-1×10-3) 
0.00 N/A 
7.598 0.0021936 12.215 0.0013644 0.0008291 
7.682 0.0021696 12.596 0.0013232 0.0008464 
7.663 0.0021750 12.635 0.0013191 0.0008559 
2.50 400 
8.163 0.0020417 11.459 0.0014545 0.0005873 
7.933 0.0021009 11.099 0.0015016 0.0005993 
7.717 0.0021597 10.712 0.0015559 0.0006038 
3.00 333 
7.502 0.0022216 10.261 0.0016243 0.0005974 
7.601 0.0021927 10.496 0.0015879 0.0006048 
7.831 0.0021283 10.877 0.0015323 0.0005960 
3.50 286 
7.521 0.0022160 10.254 0.0016254 0.0005906 
8.095 0.0020589 11.348 0.0014687 0.0005902 
8.128 0.0020505 11.476 0.0014523 0.0005982 
4.00 250 
8.040 0.0020730 11.297 0.0014753 0.0005977 
9.063 0.0018390 13.393 0.0012444 0.0005945 
9.613 0.0017338 14.619 0.0011401 0.0005937 
4.50 222 
9.223 0.0018071 13.613 0.0012243 0.0005828 
8.706 0.0019144 12.610 0.0013217 0.0005927 
9.630 0.0017307 14.487 0.0011505 0.0005802 
5.00 200 
9.154 0.0018207 13.323 0.0012510 0.0005697 
9.028 0.0018461 12.993 0.0012827 0.0005634 
9.094 0.0018327 13.330 0.0012503 0.0005824 
5.50 182 
10.000 0.0016667 15.174 0.0010984 0.0005683 
10.573 0.0015763 16.421 0.0010150 0.0005614 
9.414 0.0017704 14.020 0.0011888 0.0005816 
6.00 167 
8.629 0.0019315 12.198 0.0013663 0.0005651 
8.183 0.0020367 11.411 0.0014606 0.0005762 
8.526 0.0019548 11.926 0.0013975 0.0005573 
7.00 143 
8.303 0.0020073 11.427 0.0014585 0.0005488 
8.508 0.0019589 11.923 0.0013979 0.0005611 
8.587 0.0019409 12.048 0.0013834 0.0005576 
8.00 125 
9.041 0.0018435 12.863 0.0012957 0.0005477 
8.533 0.0019532 11.871 0.0014040 0.0005492 
9.138 0.0018239 13.074 0.0012748 0.0005491 
9.00 111 
9.018 0.0018482 12.852 0.0012968 0.0005513 
8.921 0.0018683 12.624 0.0013202 0.0005480 
9.121 0.0018273 12.938 0.0012882 0.0005391 
10.00 100 
9.041 0.0018435 12.735 0.0013087 0.0005347 
9.498 0.0017548 13.885 0.0012003 0.0005544 
10.050 0.0016584 14.936 0.0011159 0.0005425 
 
108 
 
μep             
(cm2×V-1×s-1×10-3) 
Average       
(cm2×V-1×s-1×10-3) 
STD           
(cm2×V-1×s-1×10-3) t (min) 
t average 
(min) ν=t/t0 
0.1497385 
0.1524 0.0024 
15.455 
15.929 1.000 0.1528603 15.904 
0.1545694 16.427 
0.1060614 
0.1078 0.0015 
16.394 
16.747 1.051 0.1082321 16.825 
0.1090547 17.023 
0.1078826 
0.1082 0.0009 
16.230 
16.150 1.014 0.1092246 16.220 
0.1076391 16.001 
0.1066688 
0.1071 0.0008 
16.020 
16.075 1.009 0.1065895 16.258 
0.1080383 15.948 
0.1079357 
0.1075 0.0004 
15.928 
15.958 1.002 0.1073753 15.934 
0.1072212 16.013 
0.1052458 
0.1057 0.0012 
15.893 
15.936 1.000 0.1070391 15.956 
0.1047924 15.959 
0.1028929 
0.1033 0.0017 
16.005 
16.042 1.007 0.1017440 16.025 
0.1051810 16.097 
0.1026344 
0.1030 0.0019 
16.103 
16.103 1.011 0.1013855 16.103 
0.1050433 16.103 
0.1020620 
0.1023 0.0017 
16.137 
16.157 1.014 0.1040552 16.166 
0.1006480 16.169 
0.0991084 
0.1004 0.0011 
16.237 
16.572 1.040 0.1013314 16.389 
0.1006959 17.089 
0.0989233 
0.0991 0.0001 
16.421 
16.735 1.051 0.0991891 16.848 
0.0991658 16.935 
0.0995721 
0.0986 0.0011 
16.824 
16.628 1.044 0.0989714 16.604 
0.0973597 16.456 
0.0965713 
0.0982 0.0018 
16.381 
16.396 1.029 0.1001281 16.363 
0.0979760 16.443 
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ν×μ(i)-μ(f)  
(cm2×V-1×s-1×10-3) 
Average         
(cm2×V-1×s-1×10-3) 
STD           
(cm2×V-1×s-1×10-3) 
95% CI          
(cm2×V-1×s-1×10-3) 
-0.00266 
-0.00001 0.00245 0.00277 0.00046 
0.00217 
-0.04093 
-0.03912 0.00163 0.00184 -0.03865 
-0.03778 
-0.04302 
-0.04264 0.00087 0.00098 -0.04166 
-0.04326 
-0.04475 
-0.04432 0.00082 0.00093 -0.04483 
-0.04337 
-0.04426 
-0.04469 0.00038 0.00043 -0.04482 
-0.04498 
-0.04711 
-0.04666 0.00119 0.00135 -0.04531 
-0.04756 
-0.04877 
-0.04839 0.00176 0.00199 -0.04993 
-0.04647 
-0.04864 
-0.04825 0.00188 0.00213 -0.04990 
-0.04621 
-0.04887 
-0.04868 0.00174 0.00196 -0.04685 
-0.05031 
-0.04929 
-0.04797 0.00119 0.00135 -0.04698 
-0.04764 
-0.04847 
-0.04829 0.00015 0.00018 -0.04819 
-0.04822 
-0.04846 
-0.04944 0.00119 0.00135 -0.04908 
-0.05077 
-0.05300 
-0.05130 0.00184 0.00209 -0.04934 
-0.05155 
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1/(ν×μ(i)-μ(f)) 
(V×s×cm-2) 
Average  
(V×s×cm-2) 
STD  
(V×s×cm-2) 
95% CI  
(V×s×cm-2) 
N/A N/A N/A N/A 
-24432 
-25591 1046 1184 -25875 
-26467 
-23247 
-24006 -23456 481 545 
-23114 
-22347 
-22307 -22571 423 479 
-23059 
-22592 
-22309 -22378 189 214 
-22233 
-21229 
-22069 -21442 553 626 
-21026 
-20503 
-20028 -20684 762 862 
-21520 
-20558 
-20038 -20746 818 926 
-21642 
-20461 
-21344 -20561 738 835 
-19878 
-20288 
-21287 -20855 513 581 
-20991 
-20631 
-20750 -20707 66 75 
-20740 
-20637 
-20374 -20236 484 548 
-19698 
-18869 
-20269 -19512 707 800 
-19398 
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(ν×μ(i)-μ(f))/[TM-β-CD] 
(cm2×V-1×s-1×M-1) 
Average      
(cm2×V-1×s-1×M-1) 
STD           
(cm2×V-1×s-1×M-1) 
95% CI         
(cm2×V-1×s-1×M-1) 
      
 N/A  N/A  N/A N/A  
        
-0.01637 
-0.01546 -0.01565 0.00065 0.00074 
-0.01511 
-0.01434 
-0.01389 -0.01421 0.00029 0.00033 
-0.01442 
-0.01279 
-0.01281 -0.01266 0.00023 0.00027 
-0.01239 
-0.01107 
-0.01121 -0.01117 0.00009 0.00011 
-0.01124 
-0.01047 
-0.01007 -0.01037 0.00026 0.00030 
-0.01057 
-0.00975 
-0.00999 -0.00968 0.00035 0.00040 
-0.00929 
-0.00884 
-0.00907 -0.00877 0.00034 0.00039 
-0.00840 
-0.00815 
-0.00781 -0.00811 0.00029 0.00033 
-0.00838 
-0.00704 
-0.00671 -0.00685 0.00017 0.00019 
-0.00681 
-0.00606 
-0.00602 -0.00604 0.00002 0.00002 
-0.00603 
-0.00538 
-0.00545 -0.00549 0.00013 0.00015 
-0.00564 
-0.00530 
-0.00493 -0.00513 0.00018 0.00021 
-0.00516 
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[TM-β-CD]/(ν×μ(i)-μ(f)) 
(V×s×M×cm-2) 
Average  
(V×s×M×cm-2) 
STD  
(V×s×M×cm-2) 
95% CI  
(V×s×M×cm-2) 
N/A N/A N/A N/A 
-61.08 
-64.69 -63.98 2.62 2.96 
-66.17 
-69.74 
-72.02 -70.37 1.44 1.63 
-69.34 
-78.21 
-78.07 -79.00 1.48 1.68 
-80.71 
-90.37 
-89.24 -89.51 0.76 0.86 
-88.93 
-95.53 
-99.31 -96.49 2.49 2.82 
-94.62 
-102.52 
-100.14 -103.42 3.81 4.31 
-107.60 
-113.07 
-110.21 -114.10 4.50 5.09 
-119.03 
-122.77 
-128.07 -123.37 4.43 5.01 
-119.27 
-142.01 
-149.01 -145.99 3.59 4.06 
-146.94 
-165.05 
-166.00 -165.66 0.53 0.60 
-165.92 
-185.73 
-183.36 -182.13 4.36 4.93 
-177.28 
-188.69 
-202.69 -195.12 7.07 8.00 
-193.98 
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APPENDIX C: THE DETAILED DATA TREATMENT TO CALCULATE THE X-AXIS AND 
Y-AXIS VALUES OF DOUBLE-RECIPROCAL PLOTS FOR THE ESTIMATION OF K2 
1. R-fenoprofen, 0.0 mM TM-β-CD. L=64.6 cm, l=56.0 cm. 
[TM-β-CD] 
(mM) 
1/[TM-β-CD] (M-
1) ν=t/t0 t(i) (min) 
1/t(i)    
(s-1×10-3) 
t(m)  
(min) 
1/t(m)  
(s-1×10-3) 
1/t(i)-1/t(m)  
(s-1×10-3) 
31.82 0.5238 17.41 0.9573 -0.4335 
0.00 N/A 1.000 35.34 0.4716 18.87 0.8832 -0.4116 
47.62 0.3500 21.77 0.7656 -0.4156 
47.99 0.3473 26.06 0.6395 -0.2923 
1.00 1000 0.9880 45.52 0.3661 25.44 0.6551 -0.2890 
47.23 0.3529 25.80 0.6460 -0.2931 
41.50 0.4016 25.89 0.6437 -0.2421 
2.00 500 0.9909 40.29 0.4137 25.47 0.6544 -0.2407 
40.04 0.4163 25.33 0.6580 -0.2417 
37.01 0.4503 25.36 0.6572 -0.2069 
3.00 333 0.9830 36.06 0.4622 24.94 0.6683 -0.2061 
34.45 0.4838 24.18 0.6893 -0.2055 
40.09 0.4157 27.13 0.6143 -0.1986 
4.00 250 0.9997 44.70 0.3729 29.75 0.5602 -0.1874 
49.44 0.3371 31.99 0.5210 -0.1839 
48.03 0.3470 32.55 0.5120 -0.1650 
5.00 200 1.0057 48.53 0.3434 32.71 0.5095 -0.1661 
47.11 0.3538 31.99 0.5210 -0.1672 
57.38 0.2905 37.86 0.4402 -0.1498 
6.00 167 0.9905 55.74 0.2990 37.17 0.4484 -0.1494 
54.24 0.3073 36.29 0.4593 -0.1520 
52.32 0.3186 36.77 0.4533 -0.1347 
8.00 125 1.0253 50.54 0.3298 35.89 0.4644 -0.1346 
49.02 0.3400 35.08 0.4751 -0.1351 
N/A N/A N/A N/A N/A 
10.00 100 1.0156 42.96 0.3880 32.68 0.5100 -0.1220 
43.71 0.3813 33.11 0.5034 -0.1221 
44.71 0.3728 35.03 0.4758 -0.1030 
15.00 67 1.0222 49.97 0.3335 38.49 0.4330 -0.0995 
50.45 0.3304 38.68 0.4309 -0.1005 
N/A N/A N/A N/A N/A 
35.00 29 1.1838 N/A N/A N/A N/A N/A 
51.20 0.3255 43.04 0.3872 -0.0617 
N/A N/A N/A N/A N/A 
50.00 20 1.2846 51.52 0.3235 44.63 0.3734 -0.0499 
48.17 0.3460 41.91 0.3977 -0.0517 
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µep        
(cm2×V-1×s-1×10-3) 
ν×μ(i)-μ(f)    
(cm2×V-1×s-1×10-3) 
1/(ν×μ(i)-μ(f)) 
(V×s×cm-2) 
Average 
(V×s×cm-2) 
STD  
(V×s×cm-2) 
95% CI 
(V×s×cm-2) 
-0.1568   
-0.1489 N/A, μ(f)=0.1520 N/A N/A N/A N/A 
-0.1504   
-0.1057 0.0475 21039 
-0.1046 0.0487 20536 20917 337 381 
-0.1060 0.0472 21175 
-0.0876 0.0652 15340 
-0.0871 0.0657 15219 15288 62 71 
-0.0875 0.0653 15305 
-0.0748 0.0784 12751 
-0.0746 0.0787 12705 12709 40 45 
-0.0743 0.0789 12671 
-0.0719 0.0802 12474 
-0.0678 0.0842 11872 12014 407 461 
-0.0665 0.0855 11697 
-0.0597 0.0920 10875 
-0.0601 0.0916 10921 10922 47 54 
-0.0605 0.0912 10970 
-0.0542 0.0983 10170 
-0.0540 0.0985 10156 10193 53 59 
-0.0550 0.0975 10253 
-0.0487 0.1020 9801 
-0.0487 0.1021 9798 9805 9 11 
-0.0489 0.1019 9815 
N/A N/A N/A 
-0.0442 0.1072 9332 9333 1 1 
-0.0442 0.1071 9333 
-0.0373 0.1139 8779 
-0.0360 0.1152 8680 8723 51 58 
-0.0364 0.1148 8709 
N/A N/A N/A 
N/A N/A N/A 7964 N/A N/A 
-0.0223 0.1256 7964 
N/A N/A N/A 
-0.0181 0.1288 7765 7789 35 48 
-0.0187 0.1280 7814 
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  2. R-fenoprofen, 0.2 mM TM-β-CD. L=64.6 cm, l=56.0 cm. 
[TM-β-CD] 
(mM) 
1/[TM-β-CD] 
(M-1) ν=t/t0 
t(i) 
(min) 
1/t(i)   
(s-1×10-3) 
t(m) 
(min) 
1/t(m)    
(s-1×10-3) 
1/t(i)-1/t(m)  
(s-1×10-3) 
N/A N/A N/A N/A N/A 
0.00 N/A 1.000 70.80 0.2354 26.71 0.6240 -0.3886 
51.35 0.3246 22.97 0.7256 -0.4010 
33.89 0.4918 21.38 0.7795 -0.2878 
1.00 1000 0.9880 41.45 0.4021 23.98 0.6950 -0.2929 
42.16 0.3953 24.37 0.6839 -0.2886 
36.89 0.4518 24.06 0.6927 -0.2409 
2.00 500 0.9909 36.90 0.4517 24.09 0.6919 -0.2402 
37.52 0.4442 24.01 0.6942 -0.2499 
34.15 0.4880 23.96 0.6956 -0.2076 
3.00 333 0.9830 35.05 0.4755 24.39 0.6833 -0.2078 
33.04 0.5044 23.39 0.7126 -0.2081 
36.64 0.4549 25.98 0.6415 -0.1866 
4.00 250 0.9997 36.23 0.4600 26.09 0.6388 -0.1788 
37.91 0.4396 27.04 0.6164 -0.1767 
38.39 0.4341 27.88 0.5978 -0.1637 
5.00 200 1.0057 39.16 0.4256 28.25 0.5900 -0.1644 
42.34 0.3936 30.47 0.5470 -0.1533 
40.93 0.4072 30.15 0.5528 -0.1456 
6.00 167 0.9905 41.60 0.4006 30.35 0.5491 -0.1485 
45.62 0.3653 32.33 0.5155 -0.1502 
43.42 0.3838 32.01 0.5207 -0.1368 
8.00 125 1.0253 42.56 0.3916 31.52 0.5288 -0.1372 
41.93 0.3975 31.48 0.5294 -0.1319 
38.89 0.4286 30.45 0.5473 -0.1188 
10.00 100 1.0156 38.16 0.4368 29.99 0.5557 -0.1190 
37.16 0.4485 29.33 0.5682 -0.1197 
36.09 0.4618 29.81 0.5591 -0.0973 
15.00 67 1.0222 35.42 0.4705 29.39 0.5671 -0.0965 
34.72 0.4800 28.88 0.5771 -0.0971 
N/A N/A N/A N/A N/A 
35.00 29 1.1838 44.81 0.3719 38.12 0.4372 -0.0653 
44.82 0.3719 38.12 0.4372 -0.0654 
47.22 0.3530 40.16 0.4150 -0.0620 
50.00 20 1.2846 47.59 0.3502 41.61 0.4005 -0.0503 
47.00 0.3546 41.06 0.4059 -0.0513 
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µep         
(cm2×V-1×s-1×10-3) 
ν×μ(i)-μ(f)      
(cm2×V-1×s-1×10-3) 
1/(ν×μ(i)-
μ(f)) 
(V×s×cm-2) 
Average  
(V×s×cm-2) 
STD  
(V×s×cm-2) 
95% CI  
(V×s×cm-2) 
N/A 
-0.14059 N/A, μ(f)=-0.1428 N/A N/A N/A N/A 
-0.14509   
-0.10411 0.0399 25038 
-0.10598 0.0381 26254 25506 655 741 
-0.10441 0.0396 25224 
-0.08716 0.0564 17721 
-0.08690 0.0567 17639 18053 648 733 
-0.09043 0.0532 18800 
-0.07510 0.0690 14497 
-0.07519 0.0689 14517 14517 21 24 
-0.07530 0.0688 14538 
-0.06753 0.0753 13281 
-0.06469 0.0781 12799 12919 319 361 
-0.06394 0.0789 12678 
-0.05921 0.0833 12012 
-0.05947 0.0830 12049 11852 310 351 
-0.05548 0.0870 11494 
-0.05268 0.0906 11034 
-0.05373 0.0896 11163 11145 103 117 
-0.05434 0.0890 11238 
-0.04950 0.0920 10864 
-0.04962 0.0919 10879 10799 125 142 
-0.04774 0.0939 10655 
-0.04298 0.0992 10085 
-0.04305 0.0991 10093 10100 19 21 
-0.04332 0.0988 10121 
-0.03520 0.1068 9362 
-0.03493 0.1071 9337 9351 12 14 
-0.03512 0.1069 9354 
N/A N/A N/A 
-0.02362 0.1148 8708 8709 2 3 
-0.02365 0.1148 8710 
-0.02245 0.1140 8775 
-0.01821 0.1194 8375 8519 222 252 
-0.01856 0.1190 8406 
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 3. R-fenoprofen, 0.5 mM TM-β-CD. L=64.4 cm, l=55.8 cm. 
[TM-β-CD] 
(mM) 
1/[TM-β-CD] 
(M-1) ν=t/t0 
t(i) 
(min) 
1/t(i)   
(s-1×10-3) 
t(m) 
(min) 
1/t(m)    
(s-1×10-3) 
1/t(i)-1/t(m)  
(s-1×10-3) 
93.53 0.1782 29.01 0.5745 -0.3963 
0.00 N/A 1.000 78.31 0.2128 27.50 0.6061 -0.3932 
N/A N/A N/A N/A N/A 
47.06 0.3542 25.29 0.6590 -0.3049 
1.00 1000 0.9880 52.03 0.3203 26.94 0.6187 -0.2983 
58.09 0.2869 28.17 0.5916 -0.3047 
N/A N/A N/A N/A N/A 
2.00 500 0.9909 77.84 0.2141 35.91 0.4641 -0.2500 
68.75 0.2424 34.09 0.4889 -0.2465 
58.50 0.2849 33.76 0.4937 -0.2088 
3.00 333 0.9830 56.86 0.2931 32.87 0.5070 -0.2139 
54.00 0.3086 31.95 0.5216 -0.2130 
49.61 0.3360 31.67 0.5263 -0.1903 
4.00 250 0.9997 49.40 0.3374 31.56 0.5281 -0.1907 
54.00 0.3086 33.48 0.4978 -0.1892 
N/A N/A N/A N/A N/A 
5.00 200 1.0057 50.36 0.3310 32.82 0.5078 -0.1769 
54.39 0.3064 35.03 0.4758 -0.1694 
57.73 0.2887 37.53 0.4441 -0.1554 
6.00 167 0.9905 N/A N/A N/A N/A N/A 
52.88 0.3152 35.43 0.4704 -0.1552 
48.58 0.3431 34.73 0.4799 -0.1368 
8.00 125 1.0253 49.22 0.3386 35.14 0.4743 -0.1357 
48.25 0.3454 34.39 0.4846 -0.1392 
45.70 0.3647 33.95 0.4909 -0.1262 
10.00 100 1.0156 43.34 0.3846 32.82 0.5078 -0.1233 
42.69 0.3904 32.38 0.5147 -0.1243 
42.87 0.3888 34.21 0.4872 -0.0984 
15.00 67 1.0222 43.73 0.3811 34.81 0.4788 -0.0977 
47.23 0.3529 37.08 0.4495 -0.0966 
50.24 0.3317 42.18 0.3951 -0.0634 
35.00 29 1.1838 53.36 0.3123 44.57 0.3739 -0.0616 
55.6 0.2998 46.05 0.3619 -0.0622 
58.61 0.2844 50.03 0.3331 -0.0488 
50.00 20 1.2846 55.78 0.2988 47.81 0.3486 -0.0498 
54.67 0.3049 46.89 0.3554 -0.0506 
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µep          
(cm2×V-1×s-1×10-3) 
ν×μ(i)-μ(f)   
(cm2×V-1×s-1×10-3) 
1/(ν×μ(i)-μ(f))  
(V×s×cm-2) 
Average  
(V×s×cm-2) 
STD  
(V×s×cm-2) 
95% CI  
(V×s×cm-2) 
-0.1424 
-0.1413 N/A, μ(f)=-0.1419 N/A N/A N/A N/A 
N/A 
-0.1096 0.0336 29721 
-0.1072 0.0360 27804 29068 1095 1239 
-0.1095 0.0337 29680 
N/A N/A N/A 
-0.0898 0.0529 18913 18695 309 350 
-0.0886 0.0541 18477 
-0.0750 0.0681 14676 
-0.0769 0.0663 15078 14919 214 243 
-0.0766 0.0666 15004 
-0.0684 0.0735 13601 
-0.0685 0.0734 13628 13585 53 60 
-0.0680 0.0739 13526 
N/A N/A N/A 
-0.0636 0.0780 12825 12609 305 346 
-0.0609 0.0807 12394 
-0.0558 0.0866 11550 
N/A N/A N/A 11546 5 6 
-0.0558 0.0866 11542 
-0.0492 0.0915 10931 
-0.0488 0.0919 10881 10950 80 90 
-0.0500 0.0906 11037 
-0.0454 0.0958 10435 
-0.0443 0.0969 10319 10371 59 67 
-0.0447 0.0965 10360 
-0.0354 0.1057 9457 
-0.0351 0.1060 9432 9429 30 34 
-0.0347 0.1064 9397 
-0.0228 0.1149 8701 
-0.0221 0.1157 8644 8669 29 41 
-0.0223 0.1155 8662 
-0.0175 0.1194 8376 
-0.0179 0.1189 8410 8407 30 34 
-0.0182 0.1185 8435 
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4. R-fenoprofen, 0.8 mM TM-β-CD. L=64.6 cm, l=56.0 cm. 
[TM-β-CD] 
(mM) 
1/[TM-β-CD] 
(M-1) ν=t/t0 
t(i) 
(min) 
1/t(i)   
(s-1×10-3) 
t(m) 
(min) 
1/t(m)    
(s-1×10-3) 
1/t(i)-1/t(m)  
(s-1×10-3) 
N/A N/A N/A N/A N/A 
0.00 N/A 1.000 132.33 0.1259 37.05 0.4498 -0.3239 
123.83 0.1346 31.08 0.5363 -0.4017 
74.19 0.2246 31.11 0.5357 -0.3111 
1.00 1000 0.9835 77.13 0.2161 31.67 0.5263 -0.3102 
82.37 0.2023 33.17 0.5025 -0.3001 
60.69 0.2746 32.06 0.5199 -0.2452 
2.00 500 0.9911 N/A N/A N/A N/A N/A 
65.83 0.2532 34.46 0.4837 -0.2305 
N/A N/A N/A N/A N/A 
3.00 333 0.9848 66.42 0.2509 36.24 0.4599 -0.2090 
59.97 0.2779 34.05 0.4895 -0.2116 
54.29 0.3070 33.04 0.5044 -0.1974 
4.00 250 0.9956 52.65 0.3166 32.37 0.5149 -0.1983 
N/A N/A N/A N/A N/A 
58.58 0.2845 40.85 0.4080 -0.1235 
5.00 200 1.006 55.01 0.3030 36.32 0.4589 -0.1559 
50.39 0.3308 33.96 0.4908 -0.1600 
51.46 0.3239 35.37 0.4712 -0.1473 
6.00 167 0.9873 55.81 0.2986 37.37 0.4460 -0.1474 
56.66 0.2942 37.75 0.4415 -0.1473 
55.90 0.2982 39.17 0.4255 -0.1273 
8.00 125 1.031 46.22 0.3606 34.29 0.4861 -0.1255 
48.02 0.3471 35.16 0.4740 -0.1269 
47.74 0.3491 35.89 0.4644 -0.1153 
10.00 100 1.016 54.12 0.3080 39.50 0.4219 -0.1140 
55.23 0.3018 40.43 0.4122 -0.1105 
54.63 0.3051 41.49 0.4017 -0.0966 
15.00 67 1.022 54.16 0.3077 41.67 0.4000 -0.0922 
54.85 0.3039 42.18 0.3951 -0.0913 
63.82 0.2612 51.66 0.3226 -0.0615 
35.00 29 1.184 64.94 0.2566 52.64 0.3166 -0.0600 
65.05 0.2562 53.40 0.3121 -0.0559 
N/A N/A N/A N/A N/A 
50.00 20 1.284 69.73 0.2390 57.78 0.2885 -0.0494 
64.58 0.2581 54.58 0.3054 -0.0473 
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µep        
(cm2×V-1×s-1×10-3) 
ν×μ(i)-μ(f)  
(cm2×V-1×s-1×10-3) 
1/(ν×μ(i)-μ(f)) 
(V×s×cm-2) 
Average  
(V×s×cm-2) 
STD  
(V×s×cm-2) 
95% CI  
(V×s×cm-2) 
N/A 
-0.1172 N/A, μ(f)=-0.1313 N/A N/A N/A N/A 
-0.1453 
-0.1126 0.0206 48528 
-0.1122 0.0209 47778 45703 4259 4820 
-0.1086 0.0245 40804 
-0.0887 0.0434 23062 
N/A N/A N/A 21807 1774 2459 
-0.0834 0.0487 20552 
N/A N/A N/A 
-0.0756 0.0568 17592 17737 205 285 
-0.0765 0.0559 17882 
-0.0714 0.0602 16617 
-0.0718 0.0599 16705 16661 62 86 
N/A N/A N/A 
-0.0447 0.0864 11580 
-0.0564 0.0746 13413 12894 1146 1297 
-0.0579 0.0731 13688 
-0.0533 0.0787 12711 
-0.0533 0.0787 12712 12712 1 1 
-0.0533 0.0787 12712 
-0.0461 0.0838 11933 
-0.0454 0.0845 11834 11893 52 59 
-0.0459 0.0839 11912 
-0.0417 0.0889 11245 
-0.0412 0.0894 11186 11152 113 128 
-0.0400 0.0907 11026 
-0.0350 0.0956 10463 
-0.0334 0.0972 10289 10334 113 128 
-0.0330 0.0976 10251 
-0.0222 0.1050 9527 
-0.0217 0.1056 9469 9437 110 124 
-0.0202 0.1074 9315 
N/A N/A N/A 
-0.0179 0.1083 9231 9188 60 83 
-0.0171 0.1093 9146 
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 5. R-fenoprofen, 1.0 mM TM-β-CD. L=64.6 cm, l=56.0 cm. 
[TM-β-CD] 
(mM) 
1/[TM-β-CD] 
(M-1) ν=t/t0 
t(i) 
(min) 
1/t(i)    
(s-1×10-3) 
t(m) 
(min) 
1/t(m)    
(s-1×10-3) 
1/t(i)-1/t(m)  
(s-1×10-3) 
119.16 0.1399 34.43 0.4841 -0.3442 
0.00 N/A 1.000 112.88 0.1476 32.47 0.5133 -0.3656 
110.73 0.1505 36.85 0.4523 -0.3018 
127.89 0.1303 40.34 0.4132 -0.2828 
1.00 1000 0.9835 91.89 0.1814 36.21 0.4603 -0.2789 
80.21 0.2078 33.64 0.4954 -0.2877 
113.15 0.1473 45.37 0.3673 -0.2201 
2.00 500 0.9911 100.91 0.1652 42.46 0.3925 -0.2274 
96.82 0.1721 41.72 0.3995 -0.2273 
81.31 0.2050 41.72 0.3995 -0.1945 
3.00 333 0.9848 96.12 0.1734 46.36 0.3595 -0.1861 
92.05 0.1811 46.06 0.3618 -0.1808 
89.30 0.1866 47.51 0.3508 -0.1642 
4.00 250 0.9956 76.38 0.2182 43.41 0.3839 -0.1657 
69.19 0.2409 41.15 0.4050 -0.1641 
70.89 0.2351 42.73 0.3900 -0.1549 
5.00 200 1.006 78.31 0.2128 45.50 0.3663 -0.1535 
85.15 0.1957 47.75 0.3490 -0.1533 
65.16 0.2558 42.24 0.3946 -0.1388 
6.00 167 0.9873 61.99 0.2689 40.56 0.4109 -0.1421 
66.54 0.2505 42.59 0.3913 -0.1409 
64.46 0.2586 43.69 0.3815 -0.1229 
8.00 125 1.031 82.47 0.2021 51.80 0.3218 -0.1197 
66.43 0.2509 44.67 0.3731 -0.1222 
65.22 0.2555 45.61 0.3654 -0.1099 
10.00 100 1.016 62.65 0.2660 44.27 0.3765 -0.1104 
61.53 0.2709 43.66 0.3817 -0.1109 
57.92 0.2878 44.12 0.3778 -0.0900 
15.00 67 1.022 57.00 0.2924 43.65 0.3818 -0.0894 
54.20 0.3075 41.96 0.3972 -0.0897 
54.97 0.3032 46.24 0.3604 -0.0572 
35.00 29 1.184 54.08 0.3082 45.65 0.3651 -0.0569 
N/A N/A N/A N/A N/A 
76.69 0.2173 63.64 0.2619 -0.0446 
50.00 20 1.284 83.65 0.1992 69.90 0.2384 -0.0392 
86.29 0.1931 70.28 0.2371 -0.0440 
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µep          
(cm2×V-1×s-1×10-3) 
ν×μ(i)-μ(f)     
(cm2×V-1×s-1×10-3) 
1/(ν×μ(i)-μ(f)) 
(V×s×cm-2) 
Average  
(V×s×cm-2) 
STD  
(V×s×cm-2) 
95% CI  
(V×s×cm-2) 
-0.1245 
-0.1323 N/A, μ(f)=-0.1220 N/A N/A N/A N/A 
-0.1092 
-0.1023 0.0214 46819 
-0.1009 0.0228 43940 47222 3501 3961 
-0.1041 0.0196 50906 
-0.0796 0.0431 23205 
-0.0823 0.0405 24708 24206 867 981 
-0.0823 0.0405 24705 
-0.0704 0.0527 18977 
-0.0673 0.0557 17957 18100 815 923 
-0.0654 0.0576 17365 
-0.0594 0.0629 15907 
-0.0600 0.0623 16051 15954 84 95 
-0.0594 0.0629 15904 
-0.0561 0.0656 15242 
-0.0555 0.0661 15119 15156 75 85 
-0.0555 0.0662 15106 
-0.0502 0.0724 13808 
-0.0514 0.0713 14034 13930 114 129 
-0.0510 0.0717 13950 
-0.0445 0.0761 13132 
-0.0433 0.0774 12926 13048 109 123 
-0.0442 0.0764 13087 
-0.0398 0.0816 12253 
-0.0400 0.0814 12285 12282 28 31 
-0.0401 0.0812 12308 
-0.0326 0.0887 11271 
-0.0324 0.0889 11244 11258 14 15 
-0.0325 0.0888 11257 
-0.0207 0.0975 10259 
-0.0206 0.0976 10244 10251 11 15 
N/A N/A N/A 
-0.0161 0.1013 9872 
-0.0142 0.1038 9635 9784 130 147 
-0.0159 0.1016 9846 
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   6. S-fenoprofen, 0.0 mM TM-β-CD. L=64.6 cm, l=56.0 cm. 
[TM-β-CD] 
(mM) 
1/[TM-β-CD] 
(M-1) ν=t/t0 
t(i) 
(min) 
1/t(i)   
(s-1×10-3) 
t(m) 
(min) 
1/t(m)    
(s-1×10-3) 
1/t(i)-1/t(m)  
(s-1×10-3) 
31.82 0.5238 17.41 0.9573 -0.4335 
0.00 N/A 1.000 35.34 0.4716 18.87 0.8832 -0.4116 
47.62 0.3500 21.77 0.7656 -0.4156 
47.99 0.3473 26.06 0.6395 -0.2923 
1.00 1000 0.9880 45.52 0.3661 25.44 0.6551 -0.2890 
47.23 0.3529 25.80 0.6460 -0.2931 
41.50 0.4016 25.89 0.6437 -0.2421 
2.00 500 0.9909 40.29 0.4137 25.47 0.6544 -0.2407 
40.04 0.4163 25.33 0.6580 -0.2417 
37.01 0.4503 25.36 0.6572 -0.2069 
3.00 333 0.9830 36.06 0.4622 24.94 0.6683 -0.2061 
34.45 0.4838 24.18 0.6893 -0.2055 
40.09 0.4157 27.13 0.6143 -0.1986 
4.00 250 0.9997 44.70 0.3729 29.75 0.5602 -0.1874 
49.44 0.3371 31.99 0.5210 -0.1839 
48.03 0.3470 32.55 0.5120 -0.1650 
5.00 200 1.0057 48.53 0.3434 32.71 0.5095 -0.1661 
47.11 0.3538 31.99 0.5210 -0.1672 
57.95 0.2876 37.86 0.4402 -0.1526 
6.00 167 0.9905 56.26 0.2962 37.17 0.4484 -0.1521 
54.80 0.3041 36.29 0.4593 -0.1551 
53.03 0.3143 36.77 0.4533 -0.1390 
8.00 125 1.0253 51.22 0.3254 35.89 0.4644 -0.1390 
49.66 0.3356 35.08 0.4751 -0.1395 
N/A N/A N/A N/A N/A 
10.00 100 1.0156 43.53 0.3829 32.68 0.5100 -0.1271 
44.30 0.3762 33.11 0.5034 -0.1271 
45.56 0.3658 35.03 0.4758 -0.1100 
15.00 67 1.0222 51.01 0.3267 38.49 0.4330 -0.1063 
51.43 0.3241 38.68 0.4309 -0.1068 
N/A N/A N/A N/A N/A 
35.00 29 1.1838 N/A N/A N/A N/A N/A 
52.92 0.3149 43.04 0.3872 -0.0723 
N/A N/A N/A N/A N/A 
50.00 20 1.2846 53.42 0.3120 44.63 0.3734 -0.0614 
49.74 0.3351 41.91 0.3977 -0.0626 
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µep         
(cm2×V-1×s-1×10-3) 
ν×μ(i)-μ(f)     
(cm2×V-1×s-1×10-3) 
1/(ν×μ(i)-
μ(f)) 
(V×s×cm-2) 
Average 
(V×s×cm-2) 
STD 
(V×s×cm-2) 
95% CI 
(V×s×cm-2) 
-0.1568 
-0.1489 N/A, μ(f)=-0.1520 N/A N/A N/A N/A 
-0.1504 
-0.1057 0.0475 21039 
-0.1046 0.0487 20536 20917 337 381 
-0.1060 0.0472 21175 
-0.0876 0.0652 15340 
-0.0871 0.0657 15219 15288 62 71 
-0.0875 0.0653 15305 
-0.0748 0.0784 12751 
-0.0746 0.0787 12705 12709 40 45 
-0.0743 0.0789 12671 
-0.0719 0.0802 12474 
-0.0678 0.0842 11872 12014 407 461 
-0.0665 0.0855 11697 
-0.0597 0.0920 10875 
-0.0601 0.0916 10921 10922 47 54 
-0.0605 0.0912 10970 
-0.0552 0.0973 10277 
-0.0550 0.0975 10259 10303 61 69 
-0.0561 0.0964 10373 
-0.0503 0.1004 9956 
-0.0503 0.1004 9956 9962 11 12 
-0.0505 0.1003 9974 
N/A N/A N/A 
-0.0460 0.1053 9497 9498 1 1 
-0.0460 0.1053 9499 
-0.0398 0.1113 8982 
-0.0385 0.1127 8874 8915 59 66 
-0.0386 0.1125 8889 
N/A N/A N/A 
N/A N/A N/A 7964 N/A N/A 
-0.0262 0.1210 8262 
N/A N/A N/A 
-0.0222 0.1234 8101 8119 25 35 
-0.0226 0.1229 8136 
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  7. S-fenoprofen, 0.2 mM TM-β-CD. L=64.6 cm, l=56.0 cm. 
[TM-β-CD] 
(mM) 
1/[TM-β-CD] 
(M-1) ν=t/t0 
t(i) 
(min) 
1/t(i)    
(s-1×10-3) 
t(m) 
(min) 
1/t(m)    
(s-1×10-3) 
1/t(i)-1/t(m)  
(s-1×10-3) 
N/A N/A N/A N/A N/A 
0.00 N/A 1.000 70.80 0.2354 26.71 0.6240 -0.3886 
51.35 0.3246 22.97 0.7256 -0.4010 
33.89 0.4918 21.38 0.7795 -0.2878 
1.00 1000 0.9880 41.45 0.4021 23.98 0.6950 -0.2929 
42.16 0.3953 24.37 0.6839 -0.2886 
36.89 0.4518 24.06 0.6927 -0.2409 
2.00 500 0.9909 36.90 0.4517 24.09 0.6919 -0.2402 
37.52 0.4442 24.01 0.6942 -0.2499 
34.15 0.4880 23.96 0.6956 -0.2076 
3.00 333 0.9830 35.05 0.4755 24.39 0.6833 -0.2078 
33.04 0.5044 23.39 0.7126 -0.2081 
36.64 0.4549 25.98 0.6415 -0.1866 
4.00 250 0.9997 36.23 0.4600 26.09 0.6388 -0.1788 
37.91 0.4396 27.04 0.6164 -0.1767 
38.39 0.4341 27.88 0.5978 -0.1637 
5.00 200 1.0057 39.16 0.4256 28.25 0.5900 -0.1644 
42.34 0.3936 30.47 0.5470 -0.1533 
41.23 0.4042 30.15 0.5528 -0.1486 
6.00 167 0.9905 41.88 0.3980 30.35 0.5491 -0.1512 
45.94 0.3628 32.33 0.5155 -0.1527 
43.90 0.3797 32.01 0.5207 -0.1410 
8.00 125 1.0253 43.04 0.3872 31.52 0.5288 -0.1415 
42.37 0.3934 31.48 0.5294 -0.1361 
39.36 0.4234 30.45 0.5473 -0.1239 
10.00 100 1.0156 38.60 0.4318 29.99 0.5557 -0.1240 
37.58 0.4435 29.33 0.5682 -0.1247 
   36.66 0.4546 29.81 0.5591 -0.1045 
15.00 67 1.0222 35.96 0.4635 29.39 0.5671 -0.1036 
35.24 0.4729 28.88 0.5771 -0.1042 
N/A N/A N/A N/A N/A 
35.00 29 1.1838 46.13 0.3613 38.12 0.4372 -0.0759 
46.15 0.3611 38.12 0.4372 -0.0761 
47.22 0.3530 40.16 0.4150 -0.0620 
50.00 20 1.2846 49.18 0.3389 41.61 0.4005 -0.0617 
48.61 0.3429 41.06 0.4059 -0.0630 
 
 
126 
µep         
(cm2×V-1×s-1×10-3) 
ν×μ(i)-μ(f)    
(cm2×V-1×s-1×10-3) 
1/(ν×μ(i)-
μ(f)) 
(V×s×cm-2) 
Average  
(V×s×cm-2) 
STD 
(V×s×cm-2) 
95% CI 
(V×s×cm-2) 
N/A 
-0.1406 N/A, μ(f)=-0.1428 N/A N/A N/A N/A 
-0.1451 
-0.1041 0.0399 25038 
-0.1060 0.0381 26254 25506 655 741 
-0.1044 0.0396 25224 
-0.0872 0.0564 17721 
-0.0869 0.0567 17639 18053 648 733 
-0.0904 0.0532 18800 
-0.0751 0.0690 14497 
-0.0752 0.0689 14517 14517 21 24 
-0.0753 0.0688 14538 
-0.0675 0.0753 13281 
-0.0647 0.0781 12799 12919 319 361 
-0.0639 0.0789 12678 
-0.0592 0.0833 12012 
-0.0595 0.0830 12049 11852 310 351 
-0.0555 0.0870 11494 
-0.0537 0.0896 11165 
-0.0547 0.0886 11284 11268 96 108 
-0.0553 0.0881 11355 
-0.0510 0.0905 11051 
-0.0512 0.0903 11074 10986 134 152 
-0.0492 0.0923 10832 
-0.0448 0.0973 10280 
-0.0448 0.0973 10283 10292 18 21 
-0.0451 0.0970 10313 
-0.0378 0.1042 9600 
-0.0375 0.1045 9571 9587 15 17 
-0.0377 0.1043 9589 
N/A N/A N/A 
-0.0275 0.1103 9067 9070 4 5 
-0.0275 0.1102 9073 
-0.0224 0.1140 8775 
-0.0223 0.1141 8761 8782 26 29 
-0.0228 0.1135 8811 
 
 
 
127 
      8. S-fenoprofen, 0.5 mM TM-β-CD. L=64.4 cm, l=55.8 cm. 
[TM-β-CD] 
(mM) 
1/[TM-β-CD] 
(M-1) ν=t/t0 
t(i) 
(min) 
1/t(i)   
(s-1×10-3) 
t(m) 
(min) 
1/t(m)    
(s-1×10-3) 
1/t(i)-1/t(m)  
(s-1×10-3) 
93.53 0.1782 29.01 0.5745 -0.3963 
0.00 N/A 1.000 78.31 0.2128 27.50 0.6061 -0.3932 
N/A N/A N/A N/A N/A 
47.06 0.3542 25.29 0.6590 -0.3049 
1.00 1000 0.9880 52.03 0.3203 26.94 0.6187 -0.2983 
58.09 0.2869 28.17 0.5916 -0.3047 
N/A N/A N/A N/A N/A 
2.00 500 0.9909 77.84 0.2141 35.91 0.4641 -0.2500 
68.75 0.2424 34.09 0.4889 -0.2465 
58.50 0.2849 33.76 0.4937 -0.2088 
3.00 333 0.9830 56.86 0.2931 32.87 0.5070 -0.2139 
54.00 0.3086 31.95 0.5216 -0.2130 
49.61 0.3360 31.67 0.5263 -0.1903 
4.00 250 0.9997 49.40 0.3374 31.56 0.5281 -0.1907 
54.00 0.3086 33.48 0.4978 -0.1892 
N/A N/A N/A N/A N/A 
5.00 200 1.0057 50.54 0.3298 32.82 0.5078 -0.1780 
54.74 0.3045 35.03 0.4758 -0.1713 
58.31 0.2858 37.53 0.4441 -0.1583 
6.00 167 0.9905 N/A N/A N/A N/A N/A 
53.35 0.3124 35.43 0.4704 -0.1580 
49.24 0.3385 34.73 0.4799 -0.1414 
8.00 125 1.0253 49.87 0.3342 35.14 0.4743 -0.1401 
48.88 0.3410 34.39 0.4846 -0.1437 
46.40 0.3592 33.95 0.4909 -0.1317 
10.00 100 1.0156 43.95 0.3792 32.82 0.5078 -0.1286 
43.28 0.3851 32.38 0.5147 -0.1296 
43.67 0.3817 34.21 0.4872 -0.1055 
15.00 67 1.0222 44.48 0.3747 34.81 0.4788 -0.1041 
48.16 0.3461 37.08 0.4495 -0.1034 
51.87 0.3213 42.18 0.3951 -0.0738 
35.00 29 1.1838 55.19 0.3020 44.57 0.3739 -0.0720 
57.58 0.2895 46.05 0.3619 -0.0725 
60.96 0.2734 50.03 0.3331 -0.0597 
50.00 20 1.2846 57.97 0.2875 47.81 0.3486 -0.0611 
56.82 0.2933 46.89 0.3554 -0.0621 
 
 
 
128 
µep         
(cm2×V-1×s-1×10-3) 
ν×μ(i)-μ(f)      
(cm2×V-1×s-1×10-3) 
1/(ν×μ(i)-μ(f)) 
(V×s×cm-2) 
Average 
(V×s×cm-2) 
STD 
(V×s×cm-2) 
95% CI 
(V×s×cm-2) 
-0.1424 
-0.1413 N/A, μ(f)=-0.1419 N/A N/A N/A N/A 
N/A 
-0.1096 0.0336 29721 
-0.1072 0.0360 27804 29068 1095 1239 
-0.1095 0.0337 29680 
N/A N/A N/A 
-0.0898 0.0529 18913 18695 309 350 
-0.0886 0.0541 18477 
-0.0750 0.0681 14676 
-0.0769 0.0663 15078 14919 214 243 
-0.0766 0.0666 15004 
-0.0684 0.0735 13601 
-0.0685 0.0734 13628 13585 53 60 
-0.0680 0.0739 13526 
N/A N/A N/A 
-0.0640 0.0775 12896 12700 278 314 
-0.0616 0.0800 12503 
-0.0569 0.0856 11687 
N/A N/A N/A 11681 9 10 
-0.0568 0.0857 11675 
-0.0508 0.0898 11137 
-0.0503 0.0903 11077 11152 83 94 
-0.0516 0.0890 11241 
-0.0473 0.0938 10659 
-0.0462 0.0950 10531 10587 65 74 
-0.0466 0.0946 10573 
-0.0379 0.1031 9697 
-0.0374 0.1037 9647 9656 37 42 
-0.0372 0.1039 9624 
-0.0265 0.1105 9050 
-0.0259 0.1113 8986 9013 33 46 
-0.0260 0.1111 9004 
-0.0215 0.1143 8747 
-0.0220 0.1137 8796 8792 43 48 
-0.0223 0.1132 8832 
 
 
 
 
129 
     9. S-fenoprofen, 0.8 mM TM-β-CD. L=64.6 cm, l=56.0 cm. 
[TM-β-CD] 
(mM) 
1/[TM-β-CD] 
(M-1) ν=t/t0 
t(i) 
(min) 
1/t(i)    
(s-1×10-3) 
t(m) 
(min) 
1/t(m)    
(s-1×10-3) 
1/t(i)-1/t(m)  
(s-1×10-3) 
N/A N/A N/A N/A N/A 
0.00 N/A 1.000 132.33 0.1259 37.05 0.4498 -0.3239 
123.83 0.1346 31.08 0.5363 -0.4017 
74.19 0.2246 31.11 0.5357 -0.3111 
1.00 1000 0.9835 77.13 0.2161 31.67 0.5263 -0.3102 
82.37 0.2023 33.17 0.5025 -0.3001 
60.69 0.2746 32.06 0.5199 -0.2452 
2.00 500 0.9911 N/A N/A N/A N/A N/A 
65.83 0.2532 34.46 0.4837 -0.2305 
N/A N/A N/A N/A N/A 
3.00 333 0.9848 66.42 0.2509 36.24 0.4599 -0.2090 
59.97 0.2779 34.05 0.4895 -0.2116 
54.29 0.3070 33.04 0.5044 -0.1974 
4.00 250 0.9956 52.65 0.3166 32.37 0.5149 -0.1983 
N/A N/A N/A N/A N/A 
58.63 0.2843 40.85 0.4080 -0.1237 
5.00 200 1.006 55.33 0.3012 36.32 0.4589 -0.1577 
50.07 0.3329 33.96 0.4908 -0.1579 
51.96 0.3208 35.37 0.4712 -0.1504 
6.00 167 0.9873 56.41 0.2955 37.37 0.4460 -0.1505 
57.31 0.2908 37.75 0.4415 -0.1507 
56.76 0.2936 39.17 0.4255 -0.1319 
8.00 125 1.031 46.80 0.3561 34.29 0.4861 -0.1299 
48.62 0.3428 35.16 0.4740 -0.1312 
48.46 0.3439 35.89 0.4644 -0.1205 
10.00 100 1.016 55.02 0.3029 39.50 0.4219 -0.1190 
56.10 0.2971 40.43 0.4122 -0.1151 
55.89 0.2982 41.49 0.4017 -0.1035 
15.00 67 1.022 55.34 0.3012 41.67 0.4000 -0.0988 
56.08 0.2972 42.18 0.3951 -0.0979 
66.53 0.2505 51.66 0.3226 -0.0721 
35.00 29 1.184 67.77 0.2459 52.64 0.3166 -0.0707 
67.64 0.2464 53.40 0.3121 -0.0657 
N/A N/A N/A N/A N/A 
50.00 20 1.284 N/A N/A N/A N/A N/A 
67.47 0.2470 54.58 0.3054 -0.0583 
 
 
 
130 
 
µep         
(cm2×V-1×s-1×10-3) 
ν×μ(i)-μ(f)      
(cm2×V-1×s-1×10-3) 
1/(ν×μ(i)-
μ(f)) 
(V×s×cm-2) 
Average  
(V×s×cm-2) 
STD  
(V×s×cm-2) 
95% CI  
(V×s×cm-2) 
N/A 
-0.11719 N/A, μ(f)=-0.1313 N/A N/A N/A N/A 
-0.14532 
-0.11255 0.0206 48528 
-0.11222 0.0209 47778 45703 4259 4820 
-0.10858 0.0245 40804 
-0.08873 0.0434 23062 
N/A N/A N/A 21807 1774 2459 
-0.08339 0.0487 20552 
N/A N/A N/A 
-0.07560 0.0568 17592 17737 205 285 
-0.07654 0.0559 17882 
-0.07144 0.0602 16617 
-0.07175 0.0599 16705 16661 62 86 
N/A N/A N/A 
-0.04476 0.0863 11592 
-0.05704 0.0739 13529 12889 1123 1271 
-0.05713 0.0738 13545 
-0.05443 0.0776 12893 
-0.05446 0.0775 12899 12900 7 8 
-0.05452 0.0775 12907 
-0.04771 0.0821 12178 
-0.04701 0.0828 12072 12131 54 61 
-0.04748 0.0823 12143 
-0.04358 0.0870 11491 
-0.04306 0.0875 11422 11384 130 147 
-0.04166 0.0890 11239 
-0.03745 0.0930 10749 
-0.03575 0.0948 10552 10606 125 142 
-0.03543 0.0951 10517 
-0.02609 0.1004 9959 
-0.02557 0.1010 9899 9851 139 157 
-0.02377 0.1032 9694 
N/A N/A N/A 
N/A N/A N/A 9597 N/A N/A 
-0.02111 0.1042 9597 
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     10. S-fenoprofen, 1.0 mM TM-β-CD. L=64.6 cm, l=56.0 cm. 
[TM-β-CD] 
(mM) 
1/[TM-β-CD] 
(M-1) ν=t/t0 
t(i) 
(min) 
1/t(i)   
(s-1×10-3) 
t(m) 
(min) 
1/t(m)    
(s-1×10-3) 
1/t(i)-1/t(m)  
(s-1×10-3) 
119.16 0.1399 34.43 0.4841 -0.3442 
0.00 N/A 1.000 112.88 0.1476 32.47 0.5133 -0.3656 
110.73 0.1505 36.85 0.4523 -0.3018 
127.89 0.1303 40.34 0.4132 -0.2828 
1.00 1000 0.9835 91.89 0.1814 36.21 0.4603 -0.2789 
80.21 0.2078 33.64 0.4954 -0.2877 
113.15 0.1473 45.37 0.3673 -0.2201 
2.00 500 0.9911 100.91 0.1652 42.46 0.3925 -0.2274 
96.82 0.1721 41.72 0.3995 -0.2273 
81.31 0.2050 41.72 0.3995 -0.1945 
3.00 333 0.9848 96.12 0.1734 46.36 0.3595 -0.1861 
92.05 0.1811 46.06 0.3618 -0.1808 
89.30 0.1866 47.51 0.3508 -0.1642 
4.00 250 0.9956 76.38 0.2182 43.41 0.3839 -0.1657 
69.19 0.2409 41.15 0.4050 -0.1641 
71.42 0.2334 42.73 0.3900 -0.1567 
5.00 200 1.006 79.20 0.2104 45.50 0.3663 -0.1559 
86.02 0.1938 47.75 0.3490 -0.1553 
65.94 0.2528 42.24 0.3946 -0.1418 
6.00 167 0.9873 62.72 0.2657 40.56 0.4109 -0.1452 
67.38 0.2474 42.59 0.3913 -0.1440 
65.51 0.2544 43.69 0.3815 -0.1271 
8.00 125 1.031 84.13 0.1981 51.80 0.3218 -0.1236 
67.57 0.2467 44.67 0.3731 -0.1264 
66.49 0.2507 45.61 0.3654 -0.1148 
10.00 100 1.016 63.83 0.2611 44.27 0.3765 -0.1154 
62.68 0.2659 43.66 0.3817 -0.1158 
59.25 0.2813 44.12 0.3778 -0.0965 
15.00 67 1.022 58.28 0.2860 43.65 0.3818 -0.0958 
55.37 0.3010 41.96 0.3972 -0.0962 
56.79 0.2935 46.24 0.3604 -0.0670 
35.00 29 1.184 55.84 0.2985 45.65 0.3651 -0.0666 
N/A N/A N/A N/A N/A 
80.55 0.2069 63.64 0.2619 -0.0550 
50.00 20 1.284 87.72 0.1900 69.90 0.2384 -0.0484 
91.24 0.1827 70.28 0.2371 -0.0545 
 
 
 
 
132 
µep         
(cm2×V-1×s-1×10-3) 
ν×μ(i)-μ(f)      
(cm2×V-1×s-1×10-3) 
1/(ν×μ(i)-μ(f)) 
(V×s×cm-2) 
Average 
(V×s×cm-2) 
STD 
(V×s×cm-2) 
95% CI 
(V×s×cm-2) 
-0.1245 
-0.1323 N/A, μ(f)=-0.1220 N/A N/A N/A N/A 
-0.1092 
-0.1023 0.0214 46819 
-0.1009 0.0228 43940 47222 3501 3961 
-0.1041 0.0196 50906 
-0.0796 0.0431 23205 
-0.0823 0.0405 24708 24206 867 981 
-0.0823 0.0405 24705 
-0.0704 0.0527 18977 
-0.0673 0.0557 17957 18100 815 923 
-0.0654 0.0576 17365 
-0.0594 0.0629 15907 
-0.0600 0.0623 16051 15954 84 95 
-0.0594 0.0629 15904 
-0.0567 0.0650 15391 
-0.0564 0.0653 15321 15328 60 68 
-0.0562 0.0655 15272 
-0.0513 0.0713 14017 
-0.0525 0.0701 14257 14148 122 138 
-0.0521 0.0706 14170 
-0.0460 0.0746 13404 
-0.0447 0.0759 13179 13315 120 136 
-0.0457 0.0748 13363 
-0.0415 0.0798 12528 
-0.0417 0.0796 12564 12561 32 36 
-0.0419 0.0794 12591 
-0.0349 0.0863 11583 
-0.0347 0.0866 11553 11569 15 17 
-0.0348 0.0864 11570 
-0.0242 0.0933 10716 
-0.0241 0.0935 10700 10708 12 16 
N/A N/A N/A 
-0.0199 0.0965 10367 
-0.0175 0.0995 10050 10253 176 199 
-0.0197 0.0967 10342 
 
